<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39338311</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1424-8247</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Pharmaceuticals (Basel, Switzerland)</Title><ISOAbbreviation>Pharmaceuticals (Basel)</ISOAbbreviation></Journal><ArticleTitle>Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1148</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ph17091148</ELocationID><Abstract><AbstractText>Nutritional epigenomics is exceptionally important because it describes the complex interactions among food compounds and epigenome modifications. Phytonutrients or bioactive compounds, which are secondary metabolites of plants, can protect against osteoarthritis by suppressing the expression of inflammatory and catabolic mediators, modulating epigenetic changes in DNA methylation, and the histone or chromatin remodelling of key inflammatory genes and noncoding RNAs. The combination of natural epigenetic modulators is crucial because of their additive and synergistic effects, safety and therapeutic efficacy, and lower adverse effects than conventional pharmacology in the treatment of osteoarthritis. In this review, we have summarized the chondroprotective properties of bioactive compounds used for the management, treatment, or prevention of osteoarthritis in both human and animal studies. However, further research is needed into bioactive compounds used as epigenetic modulators in osteoarthritis, in order to determine their potential value for future clinical applications in osteoarthritic patients as well as their relation with the genomic and nutritional environment, in order to personalize food and nutrition together with disease prevention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Villagrán-Andrade</LastName><ForeName>Karla Mariuxi</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Unidad de Epigenética, Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario, de A Coruña (CHUAC), Sergas, 15006 A Coruña, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Núñez-Carro</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3034-4835</Identifier><AffiliationInfo><Affiliation>Unidad de Epigenética, Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario, de A Coruña (CHUAC), Sergas, 15006 A Coruña, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0001-9821-7635</Identifier><AffiliationInfo><Affiliation>Unidad de Epigenética, Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario, de A Coruña (CHUAC), Sergas, 15006 A Coruña, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de Investigación en Reumatología y Salud, Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Facultad de Fisioterapia, Campus de Oza, Universidade da Coruña (UDC), 15008 A Coruña, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Andrés</LastName><ForeName>María C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0003-2260-6356</Identifier><AffiliationInfo><Affiliation>Unidad de Epigenética, Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario, de A Coruña (CHUAC), Sergas, 15006 A Coruña, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PI19/01213</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmaceuticals (Basel)</MedlineTA><NlmUniqueID>101238453</NlmUniqueID><ISSNLinking>1424-8247</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bioactive compounds</Keyword><Keyword MajorTopicYN="N">cartilage</Keyword><Keyword MajorTopicYN="N">chondrocyte</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">nutriepigenomics</Keyword><Keyword MajorTopicYN="N">osteoarthritis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39338311</ArticleId><ArticleId IdType="pmc">PMC11434976</ArticleId><ArticleId IdType="doi">10.3390/ph17091148</ArticleId><ArticleId IdType="pii">ph17091148</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Buckwalter J.A., Martin J.A. Osteoarthritis. Adv. Drug Deliv. Rev. 2006;58:150–167. doi: 10.1016/j.addr.2006.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2006.01.006</ArticleId><ArticleId IdType="pubmed">16530881</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks P.M. Impact of osteoarthritis on individuals and society: How much disability? Social consequences and health economic implications. Curr. Opin. Rheumatol. 2002;14:573–577. doi: 10.1097/00002281-200209000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002281-200209000-00017</ArticleId><ArticleId IdType="pubmed">12192258</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira D., Peleteiro B., Araújo J., Branco J., Santos R.A., Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: A systematic review. Osteoarthr. Cartil. 2011;19:1270–1285. doi: 10.1016/j.joca.2011.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2011.08.009</ArticleId><ArticleId IdType="pubmed">21907813</ArticleId></ArticleIdList></Reference><Reference><Citation>Malemud C.J. Biologic basis of osteoarthritis: State of the evidence. Curr. Opin. Rheumatol. 2015;27:289–294. doi: 10.1097/BOR.0000000000000162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000162</ArticleId><ArticleId IdType="pmc">PMC4492522</ArticleId><ArticleId IdType="pubmed">25784380</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieppe P.A., Lohmander L.S. Pathogenesis and management of pain in osteoarthritis. Lancet. 2005;365:965–973. doi: 10.1016/S0140-6736(05)71086-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)71086-2</ArticleId><ArticleId IdType="pubmed">15766999</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobasheri A., Fonseca J.E., Gualillo O., Henrotin Y., Largo R., Herrero-Beaumont G., Rocha F.A.C. Editorial: Inflammation and Biomarkers in Osteoarthritis. Front. Med. 2021;8:727700. doi: 10.3389/fmed.2021.727700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.727700</ArticleId><ArticleId IdType="pmc">PMC8353120</ArticleId><ArticleId IdType="pubmed">34386512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanthawang T., Bodden J., Joseph G.B., Lane N.E., Nevitt M., McCulloch C.E., Link T.M. Obese and overweight individuals have greater knee synovial inflammation and associated structural and cartilage compositional degeneration: Data from the osteoarthritis initiative. Skeletal Radiol. 2021;50:217–229. doi: 10.1007/s00256-020-03550-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00256-020-03550-5</ArticleId><ArticleId IdType="pmc">PMC7677197</ArticleId><ArticleId IdType="pubmed">32699956</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes G.S., Valdes A.M. Cardiovascular disease and osteoarthritis: Common pathways and patient outcomes. Eur. J. Clin. Investig. 2015;45:405–414. doi: 10.1111/eci.12413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12413</ArticleId><ArticleId IdType="pubmed">25630589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Ouyang H., Dass C.R., Xu J. Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res. 2016;4:15040. doi: 10.1038/boneres.2015.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/boneres.2015.40</ArticleId><ArticleId IdType="pmc">PMC4772471</ArticleId><ArticleId IdType="pubmed">26962464</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrignani P., Tacconelli S., Bruno A., Sostres C., Lanas A. Managing the adverse effects of nonsteroidal anti-inflammatory drugs. Expert. Rev. Clin. Pharmacol. 2011;4:605–621. doi: 10.1586/ecp.11.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/ecp.11.36</ArticleId><ArticleId IdType="pubmed">22114888</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng D.S., Visco C.J. Pharmaceutical therapy for osteoarthritis. PM&amp;R. 2012;4:S82–S88. doi: 10.1016/j.pmrj.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmrj.2012.02.009</ArticleId><ArticleId IdType="pubmed">22632707</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Neil C.K., Hanlon J.T., Marcum Z.A. Adverse effects of analgesics commonly used by older adults with osteoarthritis: Focus on non-opioid and opioid analgesics. Am. J. Geriatr. Pharmacother. 2012;10:331–342. doi: 10.1016/j.amjopharm.2012.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjopharm.2012.09.004</ArticleId><ArticleId IdType="pmc">PMC3529168</ArticleId><ArticleId IdType="pubmed">23036838</ArticleId></ArticleIdList></Reference><Reference><Citation>Roach H.I., Yamada N., Cheung K.S., Tilley S., Clarke N.M., Oreffo R.O., Kokubun S., Bronner F. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 2005;52:3110–3124. doi: 10.1002/art.21300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21300</ArticleId><ArticleId IdType="pubmed">16200590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird A. Perceptions of epigenetics. Nature. 2007;447:396–398. doi: 10.1038/nature05913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05913</ArticleId><ArticleId IdType="pubmed">17522671</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N.M., Haqqi T.M. Epigenetics in osteoarthritis: Potential of HDAC inhibitors as therapeutics. Pharmacol. Res. 2018;128:73–79. doi: 10.1016/j.phrs.2017.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2017.08.007</ArticleId><ArticleId IdType="pmc">PMC5803377</ArticleId><ArticleId IdType="pubmed">28827187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos Y.F., Meulenbelt I. The role of epigenetics in osteoarthritis: Current perspective. Curr. Opin. Rheumatol. 2017;29:119–129. doi: 10.1097/BOR.0000000000000355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000355</ArticleId><ArticleId IdType="pubmed">27749371</ArticleId></ArticleIdList></Reference><Reference><Citation>Im G.I., Choi Y.J. Epigenetics in osteoarthritis and its implication for future therapeutics. Expert. Opin. Biol. Ther. 2013;13:713–721. doi: 10.1517/14712598.2013.764410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.2013.764410</ArticleId><ArticleId IdType="pubmed">23410522</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J., Abu-Amer Y., O’Keefe R.J., McAlinden A. Inflammation and epigenetic regulation in osteoarthritis. Connect. Tissue Res. 2017;58:49–63. doi: 10.1080/03008207.2016.1208655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03008207.2016.1208655</ArticleId><ArticleId IdType="pmc">PMC5266560</ArticleId><ArticleId IdType="pubmed">27389927</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers E.L., Reynard L.N., Loughlin J. The role of inflammation-related genes in osteoarthritis. Osteoarthr. Cartil. 2015;23:1933–1938. doi: 10.1016/j.joca.2015.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2015.01.003</ArticleId><ArticleId IdType="pubmed">26521739</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon T.C., Jeffries M.A. The Epigenomic Landscape in Osteoarthritis. Curr. Rheumatol. Rep. 2017;19:30. doi: 10.1007/s11926-017-0661-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-017-0661-9</ArticleId><ArticleId IdType="pmc">PMC5957081</ArticleId><ArticleId IdType="pubmed">28456906</ArticleId></ArticleIdList></Reference><Reference><Citation>van Meurs J.B. Osteoarthritis year in review 2016: Genetics, genomics and epigenetics. Osteoarthr. Cartil. 2017;25:181–189. doi: 10.1016/j.joca.2016.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2016.11.011</ArticleId><ArticleId IdType="pubmed">28100422</ArticleId></ArticleIdList></Reference><Reference><Citation>Barter M.J., Bui C., Young D.A. Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthr. Cartil. 2012;20:339–349. doi: 10.1016/j.joca.2011.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2011.12.012</ArticleId><ArticleId IdType="pubmed">22281264</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee A., Eccles M.R. DNA methylation and epigenomics: New technologies and emerging concepts. Genome Biol. 2015;16:103. doi: 10.1186/s13059-015-0674-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-015-0674-5</ArticleId><ArticleId IdType="pmc">PMC4438343</ArticleId><ArticleId IdType="pubmed">25990550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Wang J. Epigenetics and Osteoarthritis. Genes. Dis. 2015;2:69–75. doi: 10.1016/j.gendis.2014.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2014.12.005</ArticleId><ArticleId IdType="pmc">PMC4421878</ArticleId><ArticleId IdType="pubmed">25961070</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano K., Boyle D.L., Firestein G.S. Regulation of DNA methylation in rheumatoid arthritis synoviocytes. J. Immunol. 2013;190:1297–1303. doi: 10.4049/jimmunol.1202572.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202572</ArticleId><ArticleId IdType="pmc">PMC3552038</ArticleId><ArticleId IdType="pubmed">23277489</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan K.E., Reddy A.B., Dietzmann K., Suriano A.R., Kocieda V.P., Stewart M., Bhatia M. Epigenetic regulation of tumor necrosis factor alpha. Mol. Cell Biol. 2007;27:5147–5160. doi: 10.1128/MCB.02429-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.02429-06</ArticleId><ArticleId IdType="pmc">PMC1951949</ArticleId><ArticleId IdType="pubmed">17515611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K., Otero M., Imagawa K., de Andrés M.C., Coico J.M., Roach H.I., Oreffo R.O.C., Marcu K.B., Goldring M.B. Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1β (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J. Biol. Chem. 2013;288:10061–10072. doi: 10.1074/jbc.M112.421156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.421156</ArticleId><ArticleId IdType="pmc">PMC3617244</ArticleId><ArticleId IdType="pubmed">23417678</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K., Oreffo R.O., Gibson M.B., Goldring M.B., Roach H.I. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum. 2009;60:3303–3313. doi: 10.1002/art.24882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24882</ArticleId><ArticleId IdType="pmc">PMC2788707</ArticleId><ArticleId IdType="pubmed">19877066</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui C., Barter M.J., Scott J.L., Xu Y., Galler M., Reynard L.N., Rowan A.D., Young D.A. cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis. FASEB J. 2012;26:3000–3011. doi: 10.1096/fj.12-206367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.12-206367</ArticleId><ArticleId IdType="pubmed">22505473</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Boeuf S., Dickhut A., Boehmer S., Olek S., Richter W. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum. 2008;58:2743–2753. doi: 10.1002/art.23736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23736</ArticleId><ArticleId IdType="pubmed">18759285</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K.S., Hashimoto K., Yamada N., Roach H.I. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol. Int. 2009;29:525–534. doi: 10.1007/s00296-008-0744-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-008-0744-z</ArticleId><ArticleId IdType="pubmed">18941754</ArticleId></ArticleIdList></Reference><Reference><Citation>Papathanasiou I., Kostopoulou F., Malizos K.N., Tsezou A. DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter. Arthritis Res. Ther. 2015;17:160. doi: 10.1186/s13075-015-0674-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-015-0674-6</ArticleId><ArticleId IdType="pmc">PMC4491261</ArticleId><ArticleId IdType="pubmed">26071314</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.I., Park Y.S., Im G.I. Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage. J. Bone Miner. Res. 2013;28:1050–1060. doi: 10.1002/jbmr.1843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.1843</ArticleId><ArticleId IdType="pubmed">23225119</ArticleId></ArticleIdList></Reference><Reference><Citation>Imagawa K., de Andrés M.C., Hashimoto K., Itoi E., Otero M., Roach H.I., Goldring M.B., Oreffo R.O. Association of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylation. Arthritis Rheumatol. 2014;66:3040–3051. doi: 10.1002/art.38774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38774</ArticleId><ArticleId IdType="pmc">PMC4211984</ArticleId><ArticleId IdType="pubmed">25048791</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi A., de Andrés M.C., Hashimoto K., Itoi E., Oreffo R.O. Epigenetic regulation of interleukin-8, an inflammatory chemokine, in osteoarthritis. Osteoarthr. Cartil. 2015;23:1946–1954. doi: 10.1016/j.joca.2015.02.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2015.02.168</ArticleId><ArticleId IdType="pmc">PMC4638192</ArticleId><ArticleId IdType="pubmed">26521741</ArticleId></ArticleIdList></Reference><Reference><Citation>de Andrés M.C., Imagawa K., Hashimoto K., Gonzalez A., Roach H.I., Goldring M.B., Oreffo R.O. Loss of methylation in CpG sites in the NF-κB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes. Arthritis Rheum. 2013;65:732–742. doi: 10.1002/art.37806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37806</ArticleId><ArticleId IdType="pmc">PMC3937961</ArticleId><ArticleId IdType="pubmed">23239081</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Zhou S., Wang C., Huang Y., Li H., Wang Y., Zhu Z., Tang J., Yan M. Epigenetic modifications of interleukin-6 in synovial fibroblasts from osteoarthritis patients. Sci. Rep. 2017;7:43592. doi: 10.1038/srep43592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43592</ArticleId><ArticleId IdType="pmc">PMC5337936</ArticleId><ArticleId IdType="pubmed">28262826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Kang D., Cho Y., Kim J.H. Epigenetic Regulation of Chondrocyte Catabolism and Anabolism in Osteoarthritis. Mol. Cells. 2015;38:677–684. doi: 10.14348/molcells.2015.0200.</Citation><ArticleIdList><ArticleId IdType="doi">10.14348/molcells.2015.0200</ArticleId><ArticleId IdType="pmc">PMC4546939</ArticleId><ArticleId IdType="pubmed">26242192</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhuri S., Cui Y., Klaassen C.D. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol. Appl. Pharmacol. 2010;245:378–393. doi: 10.1016/j.taap.2010.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2010.03.022</ArticleId><ArticleId IdType="pmc">PMC2911443</ArticleId><ArticleId IdType="pubmed">20381512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693–705. doi: 10.1016/j.cell.2007.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.02.005</ArticleId><ArticleId IdType="pubmed">17320507</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., van Kuilenburg A.B. Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem. J. 2003;370:737–749. doi: 10.1042/bj20021321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj20021321</ArticleId><ArticleId IdType="pmc">PMC1223209</ArticleId><ArticleId IdType="pubmed">12429021</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Ji L., Yang Y., Zhang X., Gang Y., Bai L. The Role of HDACs and HDACi in Cartilage and Osteoarthritis. Front. Cell Dev. Biol. 2020;8:560117. doi: 10.3389/fcell.2020.560117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.560117</ArticleId><ArticleId IdType="pmc">PMC7554620</ArticleId><ArticleId IdType="pubmed">33102472</ArticleId></ArticleIdList></Reference><Reference><Citation>Young D.A., Lakey R.L., Pennington C.J., Jones D., Kevorkian L., Edwards D.R., Cawston T.E., Clark I.M. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res. Ther. 2005;7:R503–R512. doi: 10.1186/ar1702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar1702</ArticleId><ArticleId IdType="pmc">PMC1174946</ArticleId><ArticleId IdType="pubmed">15899037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S., Derfoul A., Pereira-Mouries L., Hall D.J. A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J. 2009;23:3539–3552. doi: 10.1096/fj.09-133215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-133215</ArticleId><ArticleId IdType="pmc">PMC2747680</ArticleId><ArticleId IdType="pubmed">19561124</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber L.C., Brock M., Hemmatazad H., Giger O.T., Moritz F., Trenkmann M., Distler J.H., Gay R.E., Kolling C., Moch H., et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 2007;56:1087–1093. doi: 10.1002/art.22512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22512</ArticleId><ArticleId IdType="pubmed">17393417</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashiyama R., Miyaki S., Yamashita S., Yoshitaka T., Lindman G., Ito Y., Sasho T., Takahashi K., Lotz M., Asahara H. Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. Mod. Rheumatol. 2010;20:11–17. doi: 10.3109/s10165-009-0224-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/s10165-009-0224-7</ArticleId><ArticleId IdType="pmc">PMC2818344</ArticleId><ArticleId IdType="pubmed">19784544</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvir-Ginzberg M., Gagarina V., Lee E.J., Hall D.J. Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. J. Biol. Chem. 2008;283:36300–36310. doi: 10.1074/jbc.M803196200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M803196200</ArticleId><ArticleId IdType="pmc">PMC2605985</ArticleId><ArticleId IdType="pubmed">18957417</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvir-Ginzberg M., Mobasheri A., Kumar A. The Role of Sirtuins in Cartilage Homeostasis and Osteoarthritis. Curr. Rheumatol. Rep. 2016;18:43. doi: 10.1007/s11926-016-0591-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-016-0591-y</ArticleId><ArticleId IdType="pubmed">27289467</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Cai L., Zhang Y., Cui L., Shen G. Intra-articular resveratrol injection prevents osteoarthritis progression in a mouse model by activating SIRT1 and thereby silencing HIF-2α. J. Orthop. Res. 2015;33:1061–1070. doi: 10.1002/jor.22859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jor.22859</ArticleId><ArticleId IdType="pubmed">25737402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagarina V., Gabay O., Dvir-Ginzberg M., Lee E.J., Brady J.K., Quon M.J., Hall D.J. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum. 2010;62:1383–1392. doi: 10.1002/art.27369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.27369</ArticleId><ArticleId IdType="pmc">PMC2923474</ArticleId><ArticleId IdType="pubmed">20131294</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppenheimer H., Kumar A., Meir H., Schwartz I., Zini A., Haze A., Kandel L., Mattan Y., Liebergall M., Dvir-Ginzberg M. Set7/9 impacts COL2A1 expression through binding and repression of SirT1 histone deacetylation. J. Bone Miner. Res. 2014;29:348–360. doi: 10.1002/jbmr.2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.2052</ArticleId><ArticleId IdType="pubmed">23873758</ArticleId></ArticleIdList></Reference><Reference><Citation>Otero M., Peng H., Hachem K.E., Culley K.L., Wondimu E.B., Quinn J., Asahara H., Tsuchimochi K., Hashimoto K., Goldring M.B. ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity. Connect. Tissue Res. 2017;58:15–26. doi: 10.1080/03008207.2016.1200566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03008207.2016.1200566</ArticleId><ArticleId IdType="pmc">PMC5326708</ArticleId><ArticleId IdType="pubmed">27310669</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteagudo S., Cornelis F.M.F., Aznar-Lopez C., Yibmantasiri P., Guns L.A., Carmeliet P., Cailotto F., Lories R.J. DOT1L safeguards cartilage homeostasis and protects against osteoarthritis. Nat. Commun. 2017;8:15889. doi: 10.1038/ncomms15889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15889</ArticleId><ArticleId IdType="pmc">PMC5481839</ArticleId><ArticleId IdType="pubmed">28627522</ArticleId></ArticleIdList></Reference><Reference><Citation>Castaño Betancourt M.C., Cailotto F., Kerkhof H.J., Cornelis F.M., Doherty S.A., Hart D.J., Hofman A., Luyten F.P., Maciewicz R.A., Mangino M., et al. Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc. Natl. Acad. Sci. USA. 2012;109:8218–8223. doi: 10.1073/pnas.1119899109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1119899109</ArticleId><ArticleId IdType="pmc">PMC3361426</ArticleId><ArticleId IdType="pubmed">22566624</ArticleId></ArticleIdList></Reference><Reference><Citation>Peschansky V.J., Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics. 2014;9:3–12. doi: 10.4161/epi.27473.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/epi.27473</ArticleId><ArticleId IdType="pmc">PMC3928183</ArticleId><ArticleId IdType="pubmed">24739571</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Zhang X., Dai L., Hu X., Zhu J., Li L., Zhou C., Ao Y. Long noncoding RNA related to cartilage injury promotes chondrocyte extracellular matrix degradation in osteoarthritis. Arthritis Rheumatol. 2014;66:969–978. doi: 10.1002/art.38309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38309</ArticleId><ArticleId IdType="pubmed">24757148</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer C., Zampetaki A., Lin N.Y., Kleyer A., Perricone C., Iagnocco A., Distler A., Langley S.R., Gelse K., Sesselmann S., et al. Signature of circulating microRNAs in osteoarthritis. Ann. Rheum. Dis. 2015;74:e18. doi: 10.1136/annrheumdis-2013-204698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204698</ArticleId><ArticleId IdType="pubmed">24515954</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyaki S., Asahara H. Macro view of microRNA function in osteoarthritis. Nat. Rev. Rheumatol. 2012;8:543–552. doi: 10.1038/nrrheum.2012.128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2012.128</ArticleId><ArticleId IdType="pmc">PMC3572197</ArticleId><ArticleId IdType="pubmed">22890245</ArticleId></ArticleIdList></Reference><Reference><Citation>Sondag G.R., Haqqi T.M. The Role of MicroRNAs and Their Targets in Osteoarthritis. Curr. Rheumatol. Rep. 2016;18:56. doi: 10.1007/s11926-016-0604-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-016-0604-x</ArticleId><ArticleId IdType="pmc">PMC5294969</ArticleId><ArticleId IdType="pubmed">27402113</ArticleId></ArticleIdList></Reference><Reference><Citation>Swingler T.E., Niu L., Smith P., Paddy P., Le L., Barter M.J., Young D.A., Clark I.M. The function of microRNAs in cartilage and osteoarthritis. Clin. Exp. Rheumatol. 2019;37((Suppl. 120)):40–47.</Citation><ArticleIdList><ArticleId IdType="pubmed">31621575</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasheed Z., Al-Shobaili H.A., Rasheed N., Mahmood A., Khan M.I. MicroRNA-26a-5p regulates the expression of inducible nitric oxide synthase via activation of NF-κB pathway in human osteoarthritis chondrocytes. Arch. Biochem. Biophys. 2016;594:61–67. doi: 10.1016/j.abb.2016.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2016.02.003</ArticleId><ArticleId IdType="pubmed">26854724</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar N., Rasheed Z., Ramamurthy S., Anbazhagan A.N., Voss F.R., Haqqi T.M. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum. 2010;62:1361–1371. doi: 10.1002/art.27329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.27329</ArticleId><ArticleId IdType="pmc">PMC3139404</ArticleId><ArticleId IdType="pubmed">20131257</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.J., Cheon E.J., Kim H.A. MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes. Osteoarthr. Cartil. 2013;21:981–989. doi: 10.1016/j.joca.2013.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2013.04.012</ArticleId><ArticleId IdType="pubmed">23611898</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar N., Haqqi T.M. MicroRNA-199a* regulates the expression of cyclooxygenase-2 in human chondrocytes. Ann. Rheum. Dis. 2012;71:1073–1080. doi: 10.1136/annrheumdis-2011-200519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2011-200519</ArticleId><ArticleId IdType="pmc">PMC4509731</ArticleId><ArticleId IdType="pubmed">22294637</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao G., Zhang Z., Huang Z., Chen W., Huang G., Meng F., Kang Y. MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation. Osteoarthr. Cartil. 2017;25:521–532. doi: 10.1016/j.joca.2016.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2016.11.006</ArticleId><ArticleId IdType="pubmed">27884646</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F., Li Z., Zhang Z., Yang Z., Kang Y., Zhao X., Long D., Hu S., Gu M., He S., et al. MicroRNA-193b-3p regulates chondrogenesis and chondrocyte metabolism by targeting HDAC3. Theranostics. 2018;8:2862–2883. doi: 10.7150/thno.23547.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.23547</ArticleId><ArticleId IdType="pmc">PMC5957014</ArticleId><ArticleId IdType="pubmed">29774080</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Y.J., Li J., Yang X., Du S., Ding J., Gao Y., Zhang Y., Yang K., Chen Q. Evidence that miR-146a attenuates aging- and trauma-induced osteoarthritis by inhibiting Notch1, IL-6, and IL-1 mediated catabolism. Aging Cell. 2018;17:e12752. doi: 10.1111/acel.12752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12752</ArticleId><ArticleId IdType="pmc">PMC5946074</ArticleId><ArticleId IdType="pubmed">29575548</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.H., Shih K.S., Wu Y.W., Wang A.W., Yang C.R. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes. Osteoarthr. Cartil. 2013;21:1987–1996. doi: 10.1016/j.joca.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2013.09.008</ArticleId><ArticleId IdType="pubmed">24107356</ArticleId></ArticleIdList></Reference><Reference><Citation>Budd E., de Andrés M.C., Sanchez-Elsner T., Oreffo R.O.C. MiR-146b is down-regulated during the chondrogenic differentiation of human bone marrow derived skeletal stem cells and up-regulated in osteoarthritis. Sci. Rep. 2017;7:46704. doi: 10.1038/srep46704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep46704</ArticleId><ArticleId IdType="pmc">PMC5402270</ArticleId><ArticleId IdType="pubmed">28436462</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Zhang Z., Chang Z., Mao G., Hu S., Zeng A., Fu M. miR-193b-5p regulates chondrocytes metabolism by directly targeting histone deacetylase 7 in interleukin-1β-induced osteoarthritis. J. Cell Biochem. 2019;120:12775–12784. doi: 10.1002/jcb.28545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.28545</ArticleId><ArticleId IdType="pubmed">30854734</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukai T., Sato M., Akutsu H., Umezawa A., Mochida J. MicroRNA-199a-3p, microRNA-193b, and microRNA-320c are correlated to aging and regulate human cartilage metabolism. J. Orthop. Res. 2012;30:1915–1922. doi: 10.1002/jor.22157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jor.22157</ArticleId><ArticleId IdType="pubmed">22674437</ArticleId></ArticleIdList></Reference><Reference><Citation>Santini P., Politi L., Vedova P.D., Scandurra R., Scotto d’Abusco A. The inflammatory circuitry of miR-149 as a pathological mechanism in osteoarthritis. Rheumatol. Int. 2014;34:711–716. doi: 10.1007/s00296-013-2754-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-013-2754-8</ArticleId><ArticleId IdType="pubmed">23595570</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyaki S., Nakasa T., Otsuki S., Grogan S.P., Higashiyama R., Inoue A., Kato Y., Sato T., Lotz M.K., Asahara H. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 2009;60:2723–2730. doi: 10.1002/art.24745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24745</ArticleId><ArticleId IdType="pmc">PMC2806094</ArticleId><ArticleId IdType="pubmed">19714579</ArticleId></ArticleIdList></Reference><Reference><Citation>Araldi E., Schipani E. MicroRNA-140 and the silencing of osteoarthritis. Genes. Dev. 2010;24:1075–1080. doi: 10.1101/gad.1939310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1939310</ArticleId><ArticleId IdType="pmc">PMC2878645</ArticleId><ArticleId IdType="pubmed">20516192</ArticleId></ArticleIdList></Reference><Reference><Citation>Si H.B., Yang T.M., Li L., Tian M., Zhou L., Li D.P., Huang Q., Kang P.D., Yang J., Zhou Z.K., et al. miR-140 Attenuates the Progression of Early-Stage Osteoarthritis by Retarding Chondrocyte Senescence. Mol. Ther. Nucleic Acids. 2020;19:15–30. doi: 10.1016/j.omtn.2019.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.10.032</ArticleId><ArticleId IdType="pmc">PMC6909049</ArticleId><ArticleId IdType="pubmed">31790972</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Lin J., Zhou X., Chen X., Chen A.C., Pi B., Pan G., Pei M., Yang H., Liu T., et al. Melatonin Prevents Osteoarthritis-Induced Cartilage Degradation via Targeting MicroRNA-140. Oxid. Med. Cell Longev. 2019;2019:9705929. doi: 10.1155/2019/9705929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9705929</ArticleId><ArticleId IdType="pmc">PMC6935446</ArticleId><ArticleId IdType="pubmed">31915516</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsen T.A., de Souza G.A., Ødegaard B., Engebretsen L., Brinchmann J.E. microRNA-140 Inhibits Inflammation and Stimulates Chondrogenesis in a Model of Interleukin 1β-induced Osteoarthritis. Mol. Ther. Nucleic Acids. 2016;5:e373. doi: 10.1038/mtna.2016.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mtna.2016.64</ArticleId><ArticleId IdType="pmc">PMC5095680</ArticleId><ArticleId IdType="pubmed">27727249</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuddenham L., Wheeler G., Ntounia-Fousara S., Waters J., Hajihosseini M.K., Clark I., Dalmay T. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 2006;580:4214–4217. doi: 10.1016/j.febslet.2006.06.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2006.06.080</ArticleId><ArticleId IdType="pubmed">16828749</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods S., Charlton S., Cheung K., Hao Y., Soul J., Reynard L.N., Crowe N., Swingler T.E., Skelton A.J., Piróg K.A., et al. microRNA-seq of cartilage reveals an overabundance of miR-140-3p which contains functional isomiRs. RNA. 2020;26:1575–1588. doi: 10.1261/rna.075176.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.075176.120</ArticleId><ArticleId IdType="pmc">PMC7566571</ArticleId><ArticleId IdType="pubmed">32660984</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng L., Feng C., Wang C.X., Xu D.Y., Chen J.J., Huang J.F., Tan P.L., Shen J.M. Circulating microRNA let-7e is decreased in knee osteoarthritis, accompanied by elevated apoptosis and reduced autophagy. Int. J. Mol. Med. 2020;45:1464–1476. doi: 10.3892/ijmm.2020.4534.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2020.4534</ArticleId><ArticleId IdType="pmc">PMC7138275</ArticleId><ArticleId IdType="pubmed">32323821</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Sanchez A., Dudek K.A., Murphy C.L. Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145) J. Biol. Chem. 2012;287:916–924. doi: 10.1074/jbc.M111.302430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.302430</ArticleId><ArticleId IdType="pmc">PMC3256897</ArticleId><ArticleId IdType="pubmed">22102413</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley C.D., Gilroy D.W., Serhan C.N., Stockinger B., Tak P.P. The resolution of inflammation. Nat. Rev. Immunol. 2013;13:59–66. doi: 10.1038/nri3362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3362</ArticleId><ArticleId IdType="pubmed">23197111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenberg G.F., Artis D. Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat. Med. 2015;21:698–708. doi: 10.1038/nm.3892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3892</ArticleId><ArticleId IdType="pmc">PMC4869856</ArticleId><ArticleId IdType="pubmed">26121198</ArticleId></ArticleIdList></Reference><Reference><Citation>Medzhitov R. Inflammation 2010: New adventures of an old flame. Cell. 2010;140:771–776. doi: 10.1016/j.cell.2010.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.03.006</ArticleId><ArticleId IdType="pubmed">20303867</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr. Opin. Rheumatol. 2011;23:471–478. doi: 10.1097/BOR.0b013e328349c2b1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e328349c2b1</ArticleId><ArticleId IdType="pmc">PMC3937875</ArticleId><ArticleId IdType="pubmed">21788902</ArticleId></ArticleIdList></Reference><Reference><Citation>Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!) Osteoarthr. Cartil. 2013;21:16–21. doi: 10.1016/j.joca.2012.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2012.11.012</ArticleId><ArticleId IdType="pubmed">23194896</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson W.H., Lepus C.M., Wang Q., Raghu H., Mao R., Lindstrom T.M., Sokolove J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 2016;12:580–592. doi: 10.1038/nrrheum.2016.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.136</ArticleId><ArticleId IdType="pmc">PMC5500215</ArticleId><ArticleId IdType="pubmed">27539668</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelletier J.P., Martel-Pelletier J., Abramson S.B. Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001;44:1237–1247. doi: 10.1002/1529-0131(200106)44:6&lt;1237::AID-ART214&gt;3.0.CO;2-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200106)44:6&lt;1237::AID-ART214&gt;3.0.CO;2-F</ArticleId><ArticleId IdType="pubmed">11407681</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldring M.B., Otero M., Tsuchimochi K., Ijiri K., Li Y. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann. Rheum. Dis. 2008;67((Suppl. 3)):iii75–iii82. doi: 10.1136/ard.2008.098764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2008.098764</ArticleId><ArticleId IdType="pmc">PMC3939701</ArticleId><ArticleId IdType="pubmed">19022820</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K.H., Zaichenko L., Peter P., Davis C.R., Crowell J.A., Mantzoros C.S. Diet quality is associated with circulating C-reactive protein but not irisin levels in humans. Metabolism. 2014;63:233–241. doi: 10.1016/j.metabol.2013.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2013.10.011</ArticleId><ArticleId IdType="pmc">PMC4373656</ArticleId><ArticleId IdType="pubmed">24315778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sureda A., Bibiloni M.D.M., Julibert A., Bouzas C., Argelich E., Llompart I., Pons A., Tur J.A. Adherence to the Mediterranean Diet and Inflammatory Markers. Nutrients. 2018;10:62. doi: 10.3390/nu10010062.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10010062</ArticleId><ArticleId IdType="pmc">PMC5793290</ArticleId><ArticleId IdType="pubmed">29320413</ArticleId></ArticleIdList></Reference><Reference><Citation>Giugliano D., Ceriello A., Esposito K. The effects of diet on inflammation: Emphasis on the metabolic syndrome. J. Am. Coll. Cardiol. 2006;48:677–685. doi: 10.1016/j.jacc.2006.03.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2006.03.052</ArticleId><ArticleId IdType="pubmed">16904534</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnolo D.F., Selmin O.I. Mediterranean Diet and Prevention of Chronic Diseases. Nutr. Today. 2017;52:208–222. doi: 10.1097/NT.0000000000000228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NT.0000000000000228</ArticleId><ArticleId IdType="pmc">PMC5625964</ArticleId><ArticleId IdType="pubmed">29051674</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulze M.B., Martínez-González M.A., Fung T.T., Lichtenstein A.H., Forouhi N.G. Food based dietary patterns and chronic disease prevention. BMJ. 2018;361:k2396. doi: 10.1136/bmj.k2396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k2396</ArticleId><ArticleId IdType="pmc">PMC5996879</ArticleId><ArticleId IdType="pubmed">29898951</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas R., Sacanella E., Estruch R. The immune protective effect of the Mediterranean diet against chronic low-grade inflammatory diseases. Endocr. Metab. Immune Disord. Drug Targets. 2014;14:245–254. doi: 10.2174/1871530314666140922153350.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871530314666140922153350</ArticleId><ArticleId IdType="pmc">PMC4443792</ArticleId><ArticleId IdType="pubmed">25244229</ArticleId></ArticleIdList></Reference><Reference><Citation>Poli A., Agostoni C., Graffigna G., Bosio C., Donini L.M., Marangoni F. The complex relationship between diet, quality of life and life expectancy: A narrative review of potential determinants based on data from Italy. Eat. Weight. Disord. 2019;24:411–419. doi: 10.1007/s40519-018-0582-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40519-018-0582-2</ArticleId><ArticleId IdType="pubmed">30264391</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowakowski A.C., Graves K.Y., Sumerau J.E. Mediation analysis of relationships between chronic inflammation and quality of life in older adults. Health Qual. Life Outcomes. 2016;14:46. doi: 10.1186/s12955-016-0452-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-016-0452-4</ArticleId><ArticleId IdType="pmc">PMC4802844</ArticleId><ArticleId IdType="pubmed">27001461</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay J.A., Mathers J.C. Diet induced epigenetic changes and their implications for health. Acta Physiol. 2011;202:103–118. doi: 10.1111/j.1748-1716.2011.02278.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1748-1716.2011.02278.x</ArticleId><ArticleId IdType="pubmed">21401888</ArticleId></ArticleIdList></Reference><Reference><Citation>Milagro F.I., Mansego M.L., De Miguel C., Martínez J.A. Dietary factors, epigenetic modifications and obesity outcomes: Progresses and perspectives. Mol. Aspects Med. 2013;34:782–812. doi: 10.1016/j.mam.2012.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2012.06.010</ArticleId><ArticleId IdType="pubmed">22771541</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis C.D., Uthus E.O. DNA methylation, cancer susceptibility, and nutrient interactions. Exp. Biol. Med. 2004;229:988–995.</Citation><ArticleIdList><ArticleId IdType="pubmed">15522834</ArticleId></ArticleIdList></Reference><Reference><Citation>Widiker S., Karst S., Wagener A., Brockmann G.A. High-fat diet leads to a decreased methylation of the Mc4r gene in the obese BFMI and the lean B6 mouse lines. J. Appl. Genet. 2010;51:193–197. doi: 10.1007/BF03195727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03195727</ArticleId><ArticleId IdType="pubmed">20453306</ArticleId></ArticleIdList></Reference><Reference><Citation>Szarc vel Szic K., Declerck K., Vidaković M., Vanden Berghe W. From inflammaging to healthy aging by dietary lifestyle choices: Is epigenetics the key to personalized nutrition? Clin. Epigenetics. 2015;7:33. doi: 10.1186/s13148-015-0068-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-015-0068-2</ArticleId><ArticleId IdType="pmc">PMC4389409</ArticleId><ArticleId IdType="pubmed">25861393</ArticleId></ArticleIdList></Reference><Reference><Citation>Toopchizadeh V., Dolatkhah N., Aghamohammadi D., Rasouli M., Hashemian M. Dietary inflammatory index is associated with pain intensity and some components of quality of life in patients with knee osteoarthritis. BMC Res. Notes. 2020;13:448. doi: 10.1186/s13104-020-05277-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-020-05277-x</ArticleId><ArticleId IdType="pmc">PMC7507718</ArticleId><ArticleId IdType="pubmed">32958008</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N., Shivappa N., Stubbs B., Smith T., Hébert J.R., Cooper C., Guglielmi G., Reginster J.Y., Rizzoli R., Maggi S. The relationship between the dietary inflammatory index and prevalence of radiographic symptomatic osteoarthritis: Data from the Osteoarthritis Initiative. Eur. J. Nutr. 2019;58:253–260. doi: 10.1007/s00394-017-1589-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-017-1589-6</ArticleId><ArticleId IdType="pmc">PMC5915290</ArticleId><ArticleId IdType="pubmed">29209774</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Hebert J.R., Shivappa N., Guo J., Tao K., Zeng C., Lei G., Lin J., Zhang Y. Inflammatory potential of diet and risk of incident knee osteoarthritis: A prospective cohort study. Arthritis Res. Ther. 2020;22:209. doi: 10.1186/s13075-020-02302-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-020-02302-z</ArticleId><ArticleId IdType="pmc">PMC7488131</ArticleId><ArticleId IdType="pubmed">32912291</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavicchia P.P., Steck S.E., Hurley T.G., Hussey J.R., Ma Y., Ockene I.S., Hébert J.R. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J. Nutr. 2009;139:2365–2372. doi: 10.3945/jn.109.114025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.109.114025</ArticleId><ArticleId IdType="pmc">PMC2777480</ArticleId><ArticleId IdType="pubmed">19864399</ArticleId></ArticleIdList></Reference><Reference><Citation>Perruccio A.V., Chandran V., Power J.D., Kapoor M., Mahomed N.N., Gandhi R. Systemic inflammation and painful joint burden in osteoarthritis: A matter of sex? Osteoarthr. Cartil. 2017;25:53–59. doi: 10.1016/j.joca.2016.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2016.08.001</ArticleId><ArticleId IdType="pubmed">27546883</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson S., Englund M., Struglics A., Lohmander L.S. Interleukin-6 and tumor necrosis factor alpha in synovial fluid are associated with progression of radiographic knee osteoarthritis in subjects with previous meniscectomy. Osteoarthr. Cartil. 2015;23:1906–1914. doi: 10.1016/j.joca.2015.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2015.05.035</ArticleId><ArticleId IdType="pubmed">26521736</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Beguerie J.R., Zhang W., Blizzard L., Otahal P., Jones G., Ding C. Circulating C reactive protein in osteoarthritis: A systematic review and meta-analysis. Ann. Rheum. Dis. 2015;74:703–710. doi: 10.1136/annrheumdis-2013-204494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204494</ArticleId><ArticleId IdType="pubmed">24363360</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelletier J.P., Raynauld J.P., Caron J., Mineau F., Abram F., Dorais M., Haraoui B., Choquette D., Martel-Pelletier J. Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis. Ann. Rheum. Dis. 2010;69:2095–2101. doi: 10.1136/ard.2009.122002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2009.122002</ArticleId><ArticleId IdType="pubmed">20570834</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer J., Davison G., Marcora S.M., Mauger A.R. Effect of a Mediterranean Type Diet on Inflammatory and Cartilage Degradation Biomarkers in Patients with Osteoarthritis. J. Nutr. Health Aging. 2017;21:562–566. doi: 10.1007/s12603-016-0806-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-016-0806-y</ArticleId><ArticleId IdType="pmc">PMC5405095</ArticleId><ArticleId IdType="pubmed">28448087</ArticleId></ArticleIdList></Reference><Reference><Citation>Henríquez Sánchez P., Ruano C., de Irala J., Ruiz-Canela M., Martínez-González M.A., Sánchez-Villegas A. Adherence to the Mediterranean diet and quality of life in the SUN Project. Eur. J. Clin. Nutr. 2012;66:360–368. doi: 10.1038/ejcn.2011.146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2011.146</ArticleId><ArticleId IdType="pubmed">21847137</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaccio M., Di Castelnuovo A., Bonanni A., Costanzo S., De Lucia F., Pounis G., Zito F., Donati M.B., de Gaetano G., Iacoviello L., et al. Adherence to a Mediterranean diet is associated with a better health-related quality of life: A possible role of high dietary antioxidant content. BMJ Open. 2013;3:e003003. doi: 10.1136/bmjopen-2013-003003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2013-003003</ArticleId><ArticleId IdType="pmc">PMC3752056</ArticleId><ArticleId IdType="pubmed">23943771</ArticleId></ArticleIdList></Reference><Reference><Citation>May A.M., Struijk E.A., Fransen H.P., Onland-Moret N.C., de Wit G.A., Boer J.M., van der Schouw Y.T., Hoekstra J., Bueno-de-Mesquita H.B., Peeters P.H., et al. The impact of a healthy lifestyle on Disability-Adjusted Life Years: A prospective cohort study. BMC Med. 2015;13:39. doi: 10.1186/s12916-015-0287-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-015-0287-6</ArticleId><ArticleId IdType="pmc">PMC4362634</ArticleId><ArticleId IdType="pubmed">25858161</ArticleId></ArticleIdList></Reference><Reference><Citation>Pérez-Tasigchana R.F., León-Muñoz L.M., López-García E., Banegas J.R., Rodríguez-Artalejo F., Guallar-Castillón P. Mediterranean Diet and Health-Related Quality of Life in Two Cohorts of Community-Dwelling Older Adults. PLoS ONE. 2016;11:e0151596. doi: 10.1371/journal.pone.0151596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0151596</ArticleId><ArticleId IdType="pmc">PMC4805188</ArticleId><ArticleId IdType="pubmed">27008160</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N., Stubbs B., Noale M., Solmi M., Luchini C., Maggi S. Adherence to the Mediterranean diet is associated with better quality of life: Data from the Osteoarthritis Initiative. Am. J. Clin. Nutr. 2016;104:1403–1409. doi: 10.3945/ajcn.116.136390.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.116.136390</ArticleId><ArticleId IdType="pmc">PMC5081720</ArticleId><ArticleId IdType="pubmed">27680996</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagiotakos D.B., Pitsavos C., Stefanadis C. Dietary patterns: A Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr. Metab. Cardiovasc. Dis. 2006;16:559–568. doi: 10.1016/j.numecd.2005.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2005.08.006</ArticleId><ArticleId IdType="pubmed">17126772</ArticleId></ArticleIdList></Reference><Reference><Citation>Block G., Hartman A.M., Naughton D. A reduced dietary questionnaire: Development and validation. Epidemiology. 1990;1:58–64. doi: 10.1097/00001648-199001000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-199001000-00013</ArticleId><ArticleId IdType="pubmed">2081241</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N., Stubbs B., Noale M., Solmi M., Luchini C., Smith T.O., Cooper C., Guglielmi G., Reginster J.Y., Rizzoli R., et al. Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: Data from the osteoarthritis initiative. Clin. Nutr. 2017;36:1609–1614. doi: 10.1016/j.clnu.2016.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2016.09.035</ArticleId><ArticleId IdType="pmc">PMC5385158</ArticleId><ArticleId IdType="pubmed">27769781</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitsavos C., Panagiotakos D.B., Tzima N., Chrysohoou C., Economou M., Zampelas A., Stefanadis C. Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: The ATTICA study. Am. J. Clin. Nutr. 2005;82:694–699. doi: 10.1093/ajcn/82.3.694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/82.3.694</ArticleId><ArticleId IdType="pubmed">16155285</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzianagnostou K., Del Turco S., Pingitore A., Sabatino L., Vassalle C. The Mediterranean Lifestyle as a Non-Pharmacological and Natural Antioxidant for Healthy Aging. Antioxidants. 2015;4:719–736. doi: 10.3390/antiox4040719.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox4040719</ArticleId><ArticleId IdType="pmc">PMC4712942</ArticleId><ArticleId IdType="pubmed">26783955</ArticleId></ArticleIdList></Reference><Reference><Citation>Sánchez-Moreno C., Cano M.P., de Ancos B., Plaza L., Olmedilla B., Granado F., Martín A. Mediterranean vegetable soup consumption increases plasma vitamin C and decreases F2-isoprostanes, prostaglandin E2 and monocyte chemotactic protein-1 in healthy humans. J. Nutr. Biochem. 2006;17:183–189. doi: 10.1016/j.jnutbio.2005.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2005.07.001</ArticleId><ArticleId IdType="pubmed">16169205</ArticleId></ArticleIdList></Reference><Reference><Citation>Martín-Núñez G.M., Cabrera-Mulero R., Rubio-Martín E., Rojo-Martínez G., Olveira G., Valdés S., Soriguer F., Castaño L., Morcillo S. Methylation levels of the SCD1 gene promoter and LINE-1 repeat region are associated with weight change: An intervention study. Mol. Nutr. Food Res. 2014;58:1528–1536. doi: 10.1002/mnfr.201400079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201400079</ArticleId><ArticleId IdType="pubmed">24827925</ArticleId></ArticleIdList></Reference><Reference><Citation>Putnik P., Gabrić D., Roohinejad S., Barba F.J., Granato D., Mallikarjunan K., Lorenzo J.M., Bursać Kovačević D. An overview of organosulfur compounds from Allium spp.: From processing and preservation to evaluation of their bioavailability, antimicrobial, and anti-inflammatory properties. Food Chem. 2019;276:680–691. doi: 10.1016/j.foodchem.2018.10.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2018.10.068</ArticleId><ArticleId IdType="pubmed">30409648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain T., Tan B., Yin Y., Blachier F., Tossou M.C., Rahu N. Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxid. Med. Cell Longev. 2016;2016:7432797. doi: 10.1155/2016/7432797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/7432797</ArticleId><ArticleId IdType="pmc">PMC5055983</ArticleId><ArticleId IdType="pubmed">27738491</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziata G., Maisto M., Schisano C., Ciampaglia R., Narciso V., Tenore G.C., Novellino E. Resveratrol as a Novel Anti-Herpes Simplex Virus Nutraceutical Agent: An Overview. Viruses. 2018;10:473. doi: 10.3390/v10090473.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10090473</ArticleId><ArticleId IdType="pmc">PMC6164158</ArticleId><ArticleId IdType="pubmed">30177661</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziata G., Sanduzzi Zamparelli M., Santoro C., Ciampaglia R., Stornaiuolo M., Tenore G.C., Sanduzzi A., Novellino E. May Polyphenols Have a Role Against Coronavirus Infection? An Overview of. Front. Med. 2020;7:240. doi: 10.3389/fmed.2020.00240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00240</ArticleId><ArticleId IdType="pmc">PMC7243156</ArticleId><ArticleId IdType="pubmed">32574331</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglio R.V., Patti A.M., Cicero A.F.G., Lippi G., Rizzo M., Toth P.P., Banach M. Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases. Curr. Pharm. Des. 2018;24:239–258. doi: 10.2174/1381612824666180130112652.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612824666180130112652</ArticleId><ArticleId IdType="pubmed">29384050</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi L., Mazzitelli S., Arciello M., Capo C.R., Rotilio G. Benefits from dietary polyphenols for brain aging and Alzheimer’s disease. Neurochem. Res. 2008;33:2390–2400. doi: 10.1007/s11064-008-9696-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-008-9696-7</ArticleId><ArticleId IdType="pubmed">18415677</ArticleId></ArticleIdList></Reference><Reference><Citation>Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer. 2003;3:768–780. doi: 10.1038/nrc1189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc1189</ArticleId><ArticleId IdType="pubmed">14570043</ArticleId></ArticleIdList></Reference><Reference><Citation>Toda T., Sugioka Y., Koike T. Soybean isoflavone can protect against osteoarthritis in ovariectomized rats. J. Food Sci. Technol. 2020;57:3409–3414. doi: 10.1007/s13197-020-04374-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13197-020-04374-w</ArticleId><ArticleId IdType="pmc">PMC7374535</ArticleId><ArticleId IdType="pubmed">32728288</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Gan R.Y., Li S., Zhou Y., Li A.N., Xu D.P., Li H.B. Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases. Molecules. 2015;20:21138–21156. doi: 10.3390/molecules201219753.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules201219753</ArticleId><ArticleId IdType="pmc">PMC6331972</ArticleId><ArticleId IdType="pubmed">26633317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukhikh S., Noskova S., Ivanova S., Ulrikh E., Izgaryshev A., Babich O. Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis. Molecules. 2021;26:2391. doi: 10.3390/molecules26082391.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26082391</ArticleId><ArticleId IdType="pmc">PMC8074261</ArticleId><ArticleId IdType="pubmed">33924083</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong D.J., Choudhury M., Hirsh D.M., Hardin J.A., Cobelli N.J., Sun H.B. Nutraceuticals: Potential for chondroprotection and molecular targeting of osteoarthritis. Int. J. Mol. Sci. 2013;14:23063–23085. doi: 10.3390/ijms141123063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms141123063</ArticleId><ArticleId IdType="pmc">PMC3856106</ArticleId><ArticleId IdType="pubmed">24284399</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin K.Y., Pang K.L. Therapeutic Effects of Olive and Its Derivatives on Osteoarthritis: From Bench to Bedside. Nutrients. 2017;9:1060. doi: 10.3390/nu9101060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9101060</ArticleId><ArticleId IdType="pmc">PMC5691677</ArticleId><ArticleId IdType="pubmed">28954409</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Adamo S., Cetrullo S., Panichi V., Mariani E., Flamigni F., Borzì R.M. Nutraceutical Activity in Osteoarthritis Biology: A Focus on the Nutrigenomic Role. Cells. 2020;9:1232. doi: 10.3390/cells9051232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9051232</ArticleId><ArticleId IdType="pmc">PMC7291002</ArticleId><ArticleId IdType="pubmed">32429348</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.Z., Zhang S.N. Recent advance in treatment of osteoarthritis by bioactive components from herbal medicine. Chin. Med. 2020;15:80. doi: 10.1186/s13020-020-00363-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-020-00363-5</ArticleId><ArticleId IdType="pmc">PMC7395386</ArticleId><ArticleId IdType="pubmed">32765641</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva L.B.A.R., Pinheiro-Castro N., Novaes G.M., Pascoal G.F.L., Ong T.P. Bioactive food compounds, epigenetics and chronic disease prevention: Focus on early-life interventions with polyphenols. Food Res. Int. 2019;125:108646. doi: 10.1016/j.foodres.2019.108646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2019.108646</ArticleId><ArticleId IdType="pubmed">31554120</ArticleId></ArticleIdList></Reference><Reference><Citation>Crascì L., Lauro M.R., Puglisi G., Panico A. Natural antioxidant polyphenols on inflammation management: Anti-glycation activity vs metalloproteinases inhibition. Crit. Rev. Food Sci. Nutr. 2018;58:893–904. doi: 10.1080/10408398.2016.1229657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2016.1229657</ArticleId><ArticleId IdType="pubmed">27646710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinger M., Kumar S., Kumar V. Some Important Dietary Polyphenolic Compounds: An Anti-inflammatory and Immunoregulatory Perspective. Mini Rev. Med. Chem. 2018;18:1270–1282. doi: 10.2174/1389557517666170208143410.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557517666170208143410</ArticleId><ArticleId IdType="pubmed">28183265</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Shen T., Lou H. Dietary Polyphenols and Their Biological Significance. Int. J. Mol. Sci. 2007;8:950–988. doi: 10.3390/i8090950.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/i8090950</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey K.B., Rizvi S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell Longev. 2009;2:270–278. doi: 10.4161/oxim.2.5.9498.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/oxim.2.5.9498</ArticleId><ArticleId IdType="pmc">PMC2835915</ArticleId><ArticleId IdType="pubmed">20716914</ArticleId></ArticleIdList></Reference><Reference><Citation>Durazzo A., Lucarini M., Souto E.B., Cicala C., Caiazzo E., Izzo A.A., Novellino E., Santini A. Polyphenols: A concise overview on the chemistry, occurrence, and human health. Phytother. Res. 2019;33:2221–2243. doi: 10.1002/ptr.6419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6419</ArticleId><ArticleId IdType="pubmed">31359516</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Archivio M., Filesi C., Di Benedetto R., Gargiulo R., Giovannini C., Masella R. Polyphenols, dietary sources and bioavailability. Ann. Ist. Super. Sanita. 2007;43:348–361.</Citation><ArticleIdList><ArticleId IdType="pubmed">18209268</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Bo’ C., Bernardi S., Marino M., Porrini M., Tucci M., Guglielmetti S., Cherubini A., Carrieri B., Kirkup B., Kroon P., et al. Systematic Review on Polyphenol Intake and Health Outcomes: Is there Sufficient Evidence to Define a Health-Promoting Polyphenol-Rich Dietary Pattern? Nutrients. 2019;11:1355. doi: 10.3390/nu11061355.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11061355</ArticleId><ArticleId IdType="pmc">PMC6627994</ArticleId><ArticleId IdType="pubmed">31208133</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi D.J., Choi S.I., Choi B.R., Lee Y.S., Lee D.Y., Kim G.S. Cartilage protective and anti-analgesic effects of ALM16 on monosodium iodoacetate induced osteoarthritis in rats. BMC Complement. Altern. Med. 2019;19:325. doi: 10.1186/s12906-019-2746-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-019-2746-7</ArticleId><ArticleId IdType="pmc">PMC6873692</ArticleId><ArticleId IdType="pubmed">31752825</ArticleId></ArticleIdList></Reference><Reference><Citation>Schell J., Scofield R.H., Barrett J.R., Kurien B.T., Betts N., Lyons T.J., Zhao Y.D., Basu A. Strawberries Improve Pain and Inflammation in Obese Adults with Radiographic Evidence of Knee Osteoarthritis. Nutrients. 2017;9:949. doi: 10.3390/nu9090949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9090949</ArticleId><ArticleId IdType="pmc">PMC5622709</ArticleId><ArticleId IdType="pubmed">28846633</ArticleId></ArticleIdList></Reference><Reference><Citation>Du C., Smith A., Avalos M., South S., Crabtree K., Wang W., Kwon Y.H., Vijayagopal P., Juma S. Blueberries Improve Pain, Gait Performance, and Inflammation in Individuals with Symptomatic Knee Osteoarthritis. Nutrients. 2019;11:290. doi: 10.3390/nu11020290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11020290</ArticleId><ArticleId IdType="pmc">PMC6413191</ArticleId><ArticleId IdType="pubmed">30699971</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasheed Z., Akhtar N., Haqqi T.M. Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes. Arthritis Res. Ther. 2010;12:R195. doi: 10.1186/ar3166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3166</ArticleId><ArticleId IdType="pmc">PMC2991031</ArticleId><ArticleId IdType="pubmed">20955562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S., Wang N., Hafeez B.B., Cheruvu V.K., Haqqi T.M. Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro. J. Nutr. 2005;135:2096–2102. doi: 10.1093/jn/135.9.2096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/135.9.2096</ArticleId><ArticleId IdType="pmc">PMC1315308</ArticleId><ArticleId IdType="pubmed">16140882</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang S., Zhou W., Zhong X., Xu J., Huang H., Zheng X., Zhang J., Yang S., Shang P., Tang Q., et al. Arctigenin prevents the progression of osteoarthritis by targeting PI3K/Akt/NF-κB axis: In vitro and in vivo studies. J. Cell Mol. Med. 2020;24:4183–4193. doi: 10.1111/jcmm.15079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15079</ArticleId><ArticleId IdType="pmc">PMC7171400</ArticleId><ArticleId IdType="pubmed">32090454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z., Piao T., Wang Y., Liu J. Astragalin inhibits IL-1β-induced inflammatory mediators production in human osteoarthritis chondrocyte by inhibiting NF-κB and MAPK activation. Int. Immunopharmacol. 2015;25:83–87. doi: 10.1016/j.intimp.2015.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2015.01.018</ArticleId><ArticleId IdType="pubmed">25637445</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrotin Y.E., Sanchez C., Deberg M.A., Piccardi N., Guillou G.B., Msika P., Reginster J.Y. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. J. Rheumatol. 2003;30:1825–1834.</Citation><ArticleIdList><ArticleId IdType="pubmed">12913942</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrotin Y.E., Deberg M.A., Crielaard J.M., Piccardi N., Msika P., Sanchez C. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes. J. Rheumatol. 2006;33:1668–1678.</Citation><ArticleIdList><ArticleId IdType="pubmed">16832844</ArticleId></ArticleIdList></Reference><Reference><Citation>Au R.Y., Al-Talib T.K., Au A.Y., Phan P.V., Frondoza C.G. Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthr. Cartil. 2007;15:1249–1255. doi: 10.1016/j.joca.2007.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2007.07.009</ArticleId><ArticleId IdType="pubmed">17845860</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudarzi R., Taylor J.F., Yazdi P.G., Pedersen B.A. Effects of Arthrocen, an avocado/soy unsaponifiables agent, on inflammatory mediators and gene expression in human chondrocytes. FEBS Open Bio. 2017;7:187–194. doi: 10.1002/2211-5463.12176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.12176</ArticleId><ArticleId IdType="pmc">PMC5292663</ArticleId><ArticleId IdType="pubmed">28174685</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Zhang C., Cai L., Xie H., Hu W., Wang T., Lu D., Chen H. Baicalin suppresses IL-1β-induced expression of inflammatory cytokines via blocking NF-κB in human osteoarthritis chondrocytes and shows protective effect in mice osteoarthritis models. Int. Immunopharmacol. 2017;52:218–226. doi: 10.1016/j.intimp.2017.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2017.09.017</ArticleId><ArticleId IdType="pubmed">28942223</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.C., Lee H.P., Hung C.Y., Tsai C.H., Li T.M., Tang C.H. Berberine attenuates CCN2-induced IL-1β expression and prevents cartilage degradation in a rat model of osteoarthritis. Toxicol. Appl. Pharmacol. 2015;289:20–29. doi: 10.1016/j.taap.2015.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2015.08.020</ArticleId><ArticleId IdType="pubmed">26344001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W., Zhang H., Jin Y., Wang Q., Chen L., Feng Z., Chen H., Wu Y. Butein inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes and slows the progression of osteoarthritis in mice. Int. Immunopharmacol. 2017;42:1–10. doi: 10.1016/j.intimp.2016.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2016.11.009</ArticleId><ArticleId IdType="pubmed">27863298</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Y., Hao W., Li S. Casticin protects against IL-1β-induced inflammation in human osteoarthritis chondrocytes. Eur. J. Pharmacol. 2019;842:314–320. doi: 10.1016/j.ejphar.2018.10.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2018.10.051</ArticleId><ArticleId IdType="pubmed">30391743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q.H., Cheng Y., Chen W.P., Zhong H.M., Wang X.H. Celastrol, an inhibitor of heat shock protein 90β potently suppresses the expression of matrix metalloproteinases, inducible nitric oxide synthase and cyclooxygenase-2 in primary human osteoarthritic chondrocytes. Eur. J. Pharmacol. 2013;708:1–7. doi: 10.1016/j.ejphar.2013.01.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2013.01.057</ArticleId><ArticleId IdType="pubmed">23396231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y.C., Hsiao G., Lin K.H., Hsieh M.S., Jayakumar T., Wu T.S., Sheu J.R. Cinnamophilin isolated from Cinnamomum philippinense protects against collagen degradation in human chondrocytes. Phytother. Res. 2013;27:892–899. doi: 10.1002/ptr.4812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.4812</ArticleId><ArticleId IdType="pubmed">22903493</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z., Zheng W., Li X., Lin J., Xie C., Li H., Cheng L., Wu A., Ni W. Cryptotanshinone protects against IL-1β-induced inflammation in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice. Int. Immunopharmacol. 2017;50:161–167. doi: 10.1016/j.intimp.2017.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2017.06.017</ArticleId><ArticleId IdType="pubmed">28666239</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulze-Tanzil G., Mobasheri A., Sendzik J., John T., Shakibaei M. Effects of curcumin (diferuloylmethane) on nuclear factor kappaB signaling in interleukin-1beta-stimulated chondrocytes. Ann. N. Y. Acad. Sci. 2004;1030:578–586. doi: 10.1196/annals.1329.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1329.067</ArticleId><ArticleId IdType="pubmed">15659840</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakibaei M., Schulze-Tanzil G., John T., Mobasheri A. Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: An immunomorphological study. Ann. Anat. 2005;187:487–497. doi: 10.1016/j.aanat.2005.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aanat.2005.06.007</ArticleId><ArticleId IdType="pubmed">16320828</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakibaei M., John T., Schulze-Tanzil G., Lehmann I., Mobasheri A. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem. Pharmacol. 2007;73:1434–1445. doi: 10.1016/j.bcp.2007.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2007.01.005</ArticleId><ArticleId IdType="pubmed">17291458</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathy-Hartert M., Jacquemond-Collet I., Priem F., Sanchez C., Lambert C., Henrotin Y. Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm. Res. 2009;58:899–908. doi: 10.1007/s00011-009-0063-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-009-0063-1</ArticleId><ArticleId IdType="pubmed">19579007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuptniratsaikul V., Dajpratham P., Taechaarpornkul W., Buntragulpoontawee M., Lukkanapichonchut P., Chootip C., Saengsuwan J., Tantayakom K., Laongpech S. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: A multicenter study. Clin. Interv. Aging. 2014;9:451–458. doi: 10.2147/CIA.S58535.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S58535</ArticleId><ArticleId IdType="pmc">PMC3964021</ArticleId><ArticleId IdType="pubmed">24672232</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuptniratsaikul V., Thanakhumtorn S., Chinswangwatanakul P., Wattanamongkonsil L., Thamlikitkul V. Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. J. Altern. Complement. Med. 2009;15:891–897. doi: 10.1089/acm.2008.0186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acm.2008.0186</ArticleId><ArticleId IdType="pubmed">19678780</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinsornsak P., Niempoog S. The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: A randomized control trial. J. Med. Assoc. Thai. 2012;95((Suppl. 1)):S51–S58.</Citation><ArticleIdList><ArticleId IdType="pubmed">23964444</ArticleId></ArticleIdList></Reference><Reference><Citation>Shep D., Khanwelkar C., Gade P., Karad S. Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: A randomized open-label parallel-arm study. Trials. 2019;20:214. doi: 10.1186/s13063-019-3327-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-019-3327-2</ArticleId><ArticleId IdType="pmc">PMC6460672</ArticleId><ArticleId IdType="pubmed">30975196</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C., Luo P., Li X., Liu P., Li Y., Xu J. Nrf2/ARE is a key pathway for curcumin-mediated protection of TMJ chondrocytes from oxidative stress and inflammation. Cell Stress. Chaperones. 2020;25:395–406. doi: 10.1007/s12192-020-01079-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-020-01079-z</ArticleId><ArticleId IdType="pmc">PMC7192998</ArticleId><ArticleId IdType="pubmed">32124251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Leong D.J., Xu L., He Z., Wang A., Navati M., Kim S.J., Hirsh D.M., Hardin J.A., Cobelli N.J., et al. Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model. Arthritis Res. Ther. 2016;18:128. doi: 10.1186/s13075-016-1025-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-016-1025-y</ArticleId><ArticleId IdType="pmc">PMC4891896</ArticleId><ArticleId IdType="pubmed">27260322</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakibaei M., Mobasheri A., Buhrmann C. Curcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in human articular chondrocytes in vitro. Genes. Nutr. 2011;6:171–179. doi: 10.1007/s12263-010-0179-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12263-010-0179-5</ArticleId><ArticleId IdType="pmc">PMC3092909</ArticleId><ArticleId IdType="pubmed">21484156</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa Y., Mukai S., Yamada S., Matsuoka M., Tarumi E., Hashimoto T., Tamura C., Imaizumi A., Nishihira J., Nakamura T. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: A randomized, double-blind, placebo-controlled prospective study. J. Orthop. Sci. 2014;19:933–939. doi: 10.1007/s00776-014-0633-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00776-014-0633-0</ArticleId><ArticleId IdType="pmc">PMC4244558</ArticleId><ArticleId IdType="pubmed">25308211</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa Y., Mukai S., Yamada S., Murata S., Yabumoto H., Maeda T., Akamatsu S. The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study. Clin. Med. Insights Arthritis Musculoskelet. Disord. 2020;13:1179544120948471. doi: 10.1177/1179544120948471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179544120948471</ArticleId><ArticleId IdType="pmc">PMC7425263</ArticleId><ArticleId IdType="pubmed">32848491</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra A., Lavin P., Patwardhan B., Chitre D. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. J. Clin. Rheumatol. 2004;10:236–245. doi: 10.1097/01.rhu.0000138087.47382.6d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.rhu.0000138087.47382.6d</ArticleId><ArticleId IdType="pubmed">17043520</ArticleId></ArticleIdList></Reference><Reference><Citation>Belcaro G., Cesarone M.R., Dugall M., Pellegrini L., Ledda A., Grossi M.G., Togni S., Appendino G. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern. Med. Rev. 2010;15:337–344.</Citation><ArticleIdList><ArticleId IdType="pubmed">21194249</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim L., Kim J.Y. Chondroprotective effect of curcumin and lecithin complex in human chondrocytes stimulated by IL-1β via an anti-inflammatory mechanism. Food Sci. Biotechnol. 2019;28:547–553. doi: 10.1007/s10068-018-0470-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10068-018-0470-6</ArticleId><ArticleId IdType="pmc">PMC6431345</ArticleId><ArticleId IdType="pubmed">30956867</ArticleId></ArticleIdList></Reference><Reference><Citation>Comblain F., Sanchez C., Lesponne I., Balligand M., Serisier S., Henrotin Y. Curcuminoids extract, hydrolyzed collagen and green tea extract synergically inhibit inflammatory and catabolic mediator’s synthesis by normal bovine and osteoarthritic human chondrocytes in monolayer. PLoS ONE. 2015;10:e0121654. doi: 10.1371/journal.pone.0121654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0121654</ArticleId><ArticleId IdType="pmc">PMC4370821</ArticleId><ArticleId IdType="pubmed">25799427</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Ascola A., Irrera N., Ettari R., Bitto A., Pallio G., Mannino F., Atteritano M., Campo G.M., Minutoli L., Arcoraci V., et al. Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose-Effect Relationships in an Experimental. Front. Pharmacol. 2019;10:1347. doi: 10.3389/fphar.2019.01347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01347</ArticleId><ArticleId IdType="pmc">PMC6868087</ArticleId><ArticleId IdType="pubmed">31798452</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari-Beni M., Moravejolahkami A.R., Gorgian P., Askari G., Tarrahi M.J., Bahreini-Esfahani N. Herbal formulation “turmeric extract, black pepper, and ginger” versus Naproxen for chronic knee osteoarthritis: A randomized, double-blind, controlled clinical trial. Phytother. Res. 2020;34:2067–2073. doi: 10.1002/ptr.6671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6671</ArticleId><ArticleId IdType="pubmed">32180294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kare S.K., Vinay V., Maresz K., Prisk V., Vik H. Seed Extract-Based Botanical Compositions Alleviate Knee Pain and Improve Joint Function in Mild-to-Moderate Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Study. Evid. Based Complement. Alternat Med. 2022;2022:2226139. doi: 10.1155/2022/2226139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/2226139</ArticleId><ArticleId IdType="pmc">PMC8791717</ArticleId><ArticleId IdType="pubmed">35096104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.L., Lee H.J., Lee D.R., Choi B.K., Yang S.H. Anti-osteoarthritic Effects of an Herbal Composition LI73014F2 on Interleukin-1β-induced Primary Human Articular Chondrocytes. Molecules. 2020;25:2033. doi: 10.3390/molecules25092033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25092033</ArticleId><ArticleId IdType="pmc">PMC7249004</ArticleId><ArticleId IdType="pubmed">32349389</ArticleId></ArticleIdList></Reference><Reference><Citation>Haseeb A., Chen D., Haqqi T.M. Delphinidin inhibits IL-1β-induced activation of NF-κB by modulating the phosphorylation of IRAK-1(Ser376) in human articular chondrocytes. Rheumatology. 2013;52:998–1008. doi: 10.1093/rheumatology/kes363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kes363</ArticleId><ArticleId IdType="pmc">PMC3651611</ArticleId><ArticleId IdType="pubmed">23392593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z., Lin C., Fu C., Lu H., Jin H., Chen Q., Pan J. The protective effect of Ellagic acid (EA) in osteoarthritis: An in vitro and in vivo study. Biomed. Pharmacother. 2020;125:109845. doi: 10.1016/j.biopha.2020.109845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.109845</ArticleId><ArticleId IdType="pubmed">32058211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S., Wang N., Lalonde M., Goldberg V.M., Haqqi T.M. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J. Pharmacol. Exp. Ther. 2004;308:767–773. doi: 10.1124/jpet.103.059220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.103.059220</ArticleId><ArticleId IdType="pubmed">14600251</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang G.S., Tseng C.Y., Lee C.H., Su S.L., Lee H.S. Effects of (-)-epigallocatechin-3-gallate on cyclooxygenase 2, PGE(2), and IL-8 expression induced by IL-1beta in human synovial fibroblasts. Rheumatol. Int. 2010;30:1197–1203. doi: 10.1007/s00296-009-1128-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-009-1128-8</ArticleId><ArticleId IdType="pubmed">19777241</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Ahmed S., Islam N., Goldberg V.M., Haqqi T.M. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: Suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum. 2002;46:2079–2086. doi: 10.1002/art.10443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.10443</ArticleId><ArticleId IdType="pubmed">12209512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S., Rahman A., Hasnain A., Lalonde M., Goldberg V.M., Haqqi T.M. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic. Biol. Med. 2002;33:1097–1105. doi: 10.1016/S0891-5849(02)01004-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(02)01004-3</ArticleId><ArticleId IdType="pubmed">12374621</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Ahmed S., Malemud C.J., Goldberg V.M., Haqqi T.M. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J. Orthop. Res. 2003;21:102–109. doi: 10.1016/S0736-0266(02)00089-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0736-0266(02)00089-X</ArticleId><ArticleId IdType="pubmed">12507586</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasheed Z., Anbazhagan A.N., Akhtar N., Ramamurthy S., Voss F.R., Haqqi T.M. Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes. Arthritis Res. Ther. 2009;11:R71. doi: 10.1186/ar2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2700</ArticleId><ArticleId IdType="pmc">PMC2714117</ArticleId><ArticleId IdType="pubmed">19445683</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar N., Haqqi T.M. Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes. Arthritis Res. Ther. 2011;13:R93. doi: 10.1186/ar3368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3368</ArticleId><ArticleId IdType="pmc">PMC3218908</ArticleId><ArticleId IdType="pubmed">21682898</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata S., Hayashi S., Fujishiro T., Kawakita K., Kanzaki N., Hashimoto S., Iwasa K., Chinzei N., Kihara S., Haneda M., et al. Oxidative stress-induced apoptosis and matrix loss of chondrocytes is inhibited by eicosapentaenoic acid. J. Orthop. Res. 2015;33:359–365. doi: 10.1002/jor.22767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jor.22767</ArticleId><ArticleId IdType="pubmed">25469820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooshmand S., Soung D.Y., Lucas E.A., Madihally S.V., Levenson C.W., Arjmandi B.H. Genistein reduces the production of proinflammatory molecules in human chondrocytes. J. Nutr. Biochem. 2007;18:609–614. doi: 10.1016/j.jnutbio.2006.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2006.11.006</ArticleId><ArticleId IdType="pubmed">17368882</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F.C., Wang C.C., Lu J.W., Lee C.H., Chen S.C., Ho Y.J., Peng Y.J. Chondroprotective Effects of Genistein against Osteoarthritis Induced Joint Inflammation. Nutrients. 2019;11:1180. doi: 10.3390/nu11051180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11051180</ArticleId><ArticleId IdType="pmc">PMC6566664</ArticleId><ArticleId IdType="pubmed">31137797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Y., Liu Q., Guo P., Huang Y., Ye Z., Hu J. Anti-chondrocyte apoptosis effect of genistein in treating inflammation-induced osteoarthritis. Mol. Med. Rep. 2020;22:2032–2042. doi: 10.3892/mmr.2020.11254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11254</ArticleId><ArticleId IdType="pmc">PMC7411358</ArticleId><ArticleId IdType="pubmed">32582961</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman R.D., Marcussen K.C. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. 2001;44:2531–2538. doi: 10.1002/1529-0131(200111)44:11&lt;2531::AID-ART433&gt;3.0.CO;2-J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200111)44:11&lt;2531::AID-ART433&gt;3.0.CO;2-J</ArticleId><ArticleId IdType="pubmed">11710709</ArticleId></ArticleIdList></Reference><Reference><Citation>Naderi Z., Mozaffari-Khosravi H., Dehghan A., Nadjarzadeh A., Huseini H.F. Effect of ginger powder supplementation on nitric oxide and C-reactive protein in elderly knee osteoarthritis patients: A 12-week double-blind randomized placebo-controlled clinical trial. J. Tradit. Complement. Med. 2016;6:199–203. doi: 10.1016/j.jtcme.2014.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcme.2014.12.007</ArticleId><ArticleId IdType="pmc">PMC4936657</ArticleId><ArticleId IdType="pubmed">27419081</ArticleId></ArticleIdList></Reference><Reference><Citation>Rondanelli M., Riva A., Morazzoni P., Allegrini P., Faliva M.A., Naso M., Miccono A., Peroni G., Degli Agosti I., Perna S. The effect and safety of highly standardized Ginger (Zingiber officinale) and Echinacea (Echinacea angustifolia) extract supplementation on inflammation and chronic pain in NSAIDs poor responders. A pilot study in subjects with knee arthrosis. Nat. Prod. Res. 2017;31:1309–1313. doi: 10.1080/14786419.2016.1236097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14786419.2016.1236097</ArticleId><ArticleId IdType="pubmed">27737573</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorndoljai P., Taneepanichskul S., Niempoog S., Nimmannit U. A Comparative of Ginger Extract in Nanostructure Lipid Carrier (NLC) and 1% Diclofenac Gel for Treatment of Knee Osteoarthritis (OA) J. Med. Assoc. Thai. 2017;100:447–456.</Citation><ArticleIdList><ArticleId IdType="pubmed">29911849</ArticleId></ArticleIdList></Reference><Reference><Citation>Rondanelli M., Riva A., Allegrini P., Faliva M.A., Naso M., Peroni G., Nichetti M., Gasparri C., Spadaccini D., Iannello G., et al. The Use of a New Food-Grade Lecithin Formulation of Highly Standardized Ginger (Zingiber officinale) and Acmella Oleracea Extracts for the Treatment of Pain and Inflammation in a Group of Subjects with Moderate Knee Osteoarthritis. J. Pain. Res. 2020;13:761–770. doi: 10.2147/JPR.S214488.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S214488</ArticleId><ArticleId IdType="pmc">PMC7183537</ArticleId><ArticleId IdType="pubmed">32368129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariano A., Di Sotto A., Leopizzi M., Garzoli S., Di Maio V., Gullì M., Dalla Vedova P., Ammendola S., Scotto d’Abusco A. Antiarthritic Effects of a Root Extract from. Nutrients. 2020;12:2545. doi: 10.3390/nu12092545.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12092545</ArticleId><ArticleId IdType="pmc">PMC7551290</ArticleId><ArticleId IdType="pubmed">32842461</ArticleId></ArticleIdList></Reference><Reference><Citation>Haseeb A., Ansari M.Y., Haqqi T.M. Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes. J. Orthop. Res. 2017;35:311–320. doi: 10.1002/jor.23262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jor.23262</ArticleId><ArticleId IdType="pmc">PMC5065736</ArticleId><ArticleId IdType="pubmed">27082319</ArticleId></ArticleIdList></Reference><Reference><Citation>Chantre P., Cappelaere A., Leblan D., Guedon D., Vandermander J., Fournie B. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine. 2000;7:177–183. doi: 10.1016/S0944-7113(00)80001-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0944-7113(00)80001-X</ArticleId><ArticleId IdType="pubmed">11185727</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblan D., Chantre P., Fournié B. Harpagophytum procumbens in the treatment of knee and hip osteoarthritis. Four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine. 2000;67:462–467.</Citation><ArticleIdList><ArticleId IdType="pubmed">11143915</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulze-Tanzil G., Hansen C., Shakibaei M. Effect of a Harpagophytum procumbens DC extract on matrix metalloproteinases in human chondrocytes in vitro. Arzneimittelforschung. 2004;54:213–220. doi: 10.1055/s-0031-1296962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1296962</ArticleId><ArticleId IdType="pubmed">15146934</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda R., Koike T., Taniguchi I., Tanaka K. Double-blind placebo-controlled trial of hydroxytyrosol of Olea europaea on pain in gonarthrosis. Phytomedicine. 2013;20:861–864. doi: 10.1016/j.phymed.2013.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2013.03.021</ArticleId><ArticleId IdType="pubmed">23746949</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmazoglu Z., Colakoglu M., Banerjee S., Bitik B., Aktekin C.N., Goker B., Karasu C. AB0090 Verbascoside and hydroxytyrosol downregulate stress-related pathways in human osteoarthritic articular chondrocytes. Ann. Rheum. Dis. 2018;77:1241.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wauquier F., Mevel E., Krisa S., Richard T., Valls J., Hornedo-Ortega R., Granel H., Boutin-Wittrant L., Urban N., Berger J., et al. Chondroprotective Properties of Human-Enriched Serum Following Polyphenol Extract Absorption: Results from an Exploratory Clinical Trial. Nutrients. 2019;11:3071. doi: 10.3390/nu11123071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11123071</ArticleId><ArticleId IdType="pmc">PMC6950735</ArticleId><ArticleId IdType="pubmed">31888255</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Zhang Y., Chen N., Yang L. Icariin Regulates Cellular Functions and Gene Expression of Osteoarthritis Patient-Derived Human Fibroblast-Like Synoviocytes. Int. J. Mol. Sci. 2017;18:2656. doi: 10.3390/ijms18122656.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18122656</ArticleId><ArticleId IdType="pmc">PMC5751258</ArticleId><ArticleId IdType="pubmed">29292760</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng L., Rong X.F., Li R.H., Wu X.Y. Icariin inhibits MMP-1, MMP-3 and MMP-13 expression through MAPK pathways in IL-1β-stimulated SW1353 chondrosarcoma cells. Mol. Med. Rep. 2017;15:2853–2858. doi: 10.3892/mmr.2017.6312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6312</ArticleId><ArticleId IdType="pubmed">28447732</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo S., Zou W., Wu R.M., Yang J., Fan J.N., Zhao X.K., Li H.Y. Icariin Alleviates IL-1β-Induced Matrix Degradation By Activating The Nrf2/ARE Pathway In Human Chondrocytes. Drug Des. Devel Ther. 2019;13:3949–3961. doi: 10.2147/DDDT.S203094.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S203094</ArticleId><ArticleId IdType="pmc">PMC6876636</ArticleId><ArticleId IdType="pubmed">31819369</ArticleId></ArticleIdList></Reference><Reference><Citation>Piscoya J., Rodriguez Z., Bustamante S.A., Okuhama N.N., Miller M.J., Sandoval M. Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee: Mechanisms of action of the species Uncaria guianensis. Inflamm. Res. 2001;50:442–448. doi: 10.1007/PL00000268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00000268</ArticleId><ArticleId IdType="pubmed">11603848</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Yu X., Hu Z., Tang S., Zhong X., Xu J., Shang P., Huang Y., Liu H. Isofraxidin targets the TLR4/MD-2 axis to prevent osteoarthritis development. Food Funct. 2018;9:5641–5652. doi: 10.1039/C8FO01445K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8FO01445K</ArticleId><ArticleId IdType="pubmed">30299441</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J., Li X., Qi W., Yan Y., Chen K., Xue X., Xu X., Feng Z., Pan X. Isofraxidin inhibits interleukin-1β induced inflammatory response in human osteoarthritis chondrocytes. Int. Immunopharmacol. 2018;64:238–245. doi: 10.1016/j.intimp.2018.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2018.09.003</ArticleId><ArticleId IdType="pubmed">30205322</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Zhang C., Wang X., Huo S. Juglanin inhibits IL-1β-induced inflammation in human chondrocytes. Artif. Cells Nanomed. Biotechnol. 2019;47:3614–3620. doi: 10.1080/21691401.2019.1657877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21691401.2019.1657877</ArticleId><ArticleId IdType="pubmed">31468982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia T., Qiao J., Guan D., Chen T. Anti-Inflammatory Effects of Licochalcone A on IL-1β-Stimulated Human Osteoarthritis Chondrocytes. Inflammation. 2017;40:1894–1902. doi: 10.1007/s10753-017-0630-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-017-0630-5</ArticleId><ArticleId IdType="pubmed">28756519</ArticleId></ArticleIdList></Reference><Reference><Citation>de Andrés M.C., Meiss M.S., Sánchez-Hidalgo M., González-Benjumea A., Fernández-Bolaños J.G., Alarcón-de-la-Lastra C., Oreffo R.O. Osteoarthritis treatment with a novel nutraceutical acetylated ligstroside aglycone, a chemically modified extra-virgin olive oil polyphenol. J. Tissue Eng. 2020;11:2041731420922701. doi: 10.1177/2041731420922701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2041731420922701</ArticleId><ArticleId IdType="pmc">PMC7257837</ArticleId><ArticleId IdType="pubmed">32523668</ArticleId></ArticleIdList></Reference><Reference><Citation>Rufino A.T., Ribeiro M., Sousa C., Judas F., Salgueiro L., Cavaleiro C., Mendes A.F. Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. Eur. J. Pharmacol. 2015;750:141–150. doi: 10.1016/j.ejphar.2015.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2015.01.018</ArticleId><ArticleId IdType="pubmed">25622554</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X., Chen T., Zhang Z., Chen X., Chen C., Chen L., Wang X., Ying X. Activation of Nrf2/HO-1 signal with Myricetin for attenuating ECM degradation in human chondrocytes and ameliorating the murine osteoarthritis. Int. Immunopharmacol. 2019;75:105742. doi: 10.1016/j.intimp.2019.105742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2019.105742</ArticleId><ArticleId IdType="pubmed">31325727</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotece M., Conde J., Abella V., López V., Francisco V., Ruiz C., Campos V., Lago F., Gomez R., Pino J., et al. Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways. Cell Physiol. Biochem. 2018;49:2414–2426. doi: 10.1159/000493840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493840</ArticleId><ArticleId IdType="pubmed">30261513</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z., Li X., Lin J., Zheng W., Hu Z., Xuan J., Ni W., Pan X. Oleuropein inhibits the IL-1β-induced expression of inflammatory mediators by suppressing the activation of NF-κB and MAPKs in human osteoarthritis chondrocytes. Food Funct. 2017;8:3737–3744. doi: 10.1039/C7FO00823F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C7FO00823F</ArticleId><ArticleId IdType="pubmed">28952621</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela-Eirín M., Carpintero-Fernández P., Sánchez-Temprano A., Varela-Vázquez A., Paíno C.L., Casado-Díaz A., Continente A.C., Mato V., Fonseca E., Kandouz M., et al. Senolytic activity of small molecular polyphenols from olive restores chondrocyte redifferentiation and promotes a pro-regenerative environment in osteoarthritis. Aging. 2020;12:15882–15905. doi: 10.18632/aging.103801.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103801</ArticleId><ArticleId IdType="pmc">PMC7485729</ArticleId><ArticleId IdType="pubmed">32745074</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmazoglu Z., Bek Z.A., Sarıbaş G.S., Özoğul C., Goker B., Bitik B., Aktekin C.N., Karasu Ç. TLR4, RAGE, and p-JNK/JNK mediated inflammatory aggression in osteoathritic human chondrocytes are counteracted by redox-sensitive phenolic olive compounds: Comparison with ibuprofen. J. Tissue Eng. Regen. Med. 2020;14:1841–1857. doi: 10.1002/term.3138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/term.3138</ArticleId><ArticleId IdType="pubmed">33010113</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng L., Xie Z., Pei J., Wang B., Gao Y., Qu Y. Puerarin alters the function of monocytes/macrophages and exhibits chondroprotection in mice. Mol. Med. Rep. 2019;19:2876–2882. doi: 10.3892/mmr.2019.9936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.9936</ArticleId><ArticleId IdType="pubmed">30720093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma D., Yu T., Peng L., Wang L., Liao Z., Xu W. PIM1, CYP1B1, and HSPA2 Targeted by Quercetin Play Important Roles in Osteoarthritis Treatment by. Evid. Based Complement. Alternat Med. 2019;2019:1205942. doi: 10.1155/2019/1205942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1205942</ArticleId><ArticleId IdType="pmc">PMC6964619</ArticleId><ArticleId IdType="pubmed">31998395</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Liu X., Yang Y., He J., Gu H., Jiang M., Huang Y., Liu L. Resveratrol inhibits the development of obesity-related osteoarthritis via the TLR4 and PI3K/Akt signaling pathways. Connect. Tissue Res. 2019;60:571–582. doi: 10.1080/03008207.2019.1601187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03008207.2019.1601187</ArticleId><ArticleId IdType="pubmed">30922122</ArticleId></ArticleIdList></Reference><Reference><Citation>Marouf B.H., Hussain S.A., Ali Z.S., Ahmmad R.S. Resveratrol Supplementation Reduces Pain and Inflammation in Knee Osteoarthritis Patients Treated with Meloxicam: A Randomized Placebo-Controlled Study. J. Med. Food. 2018;21:1253–1259. doi: 10.1089/jmf.2017.4176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2017.4176</ArticleId><ArticleId IdType="pubmed">30160612</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakibaei M., John T., Seifarth C., Mobasheri A. Resveratrol inhibits IL-1 beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann. N. Y. Acad. Sci. 2007;1095:554–563. doi: 10.1196/annals.1397.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1397.060</ArticleId><ArticleId IdType="pubmed">17404069</ArticleId></ArticleIdList></Reference><Reference><Citation>Csaki C., Keshishzadeh N., Fischer K., Shakibaei M. Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem. Pharmacol. 2008;75:677–687. doi: 10.1016/j.bcp.2007.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2007.09.014</ArticleId><ArticleId IdType="pubmed">17959154</ArticleId></ArticleIdList></Reference><Reference><Citation>Dave M., Attur M., Palmer G., Al-Mussawir H.E., Kennish L., Patel J., Abramson S.B. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum. 2008;58:2786–2797. doi: 10.1002/art.23799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23799</ArticleId><ArticleId IdType="pubmed">18759268</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Liu X., Yang Y., He J., Jiang M., Huang Y., Liu L., Gu H. Resveratrol Exerts Anti-Osteoarthritic Effect by Inhibiting TLR4/NF-κB Signaling Pathway via the TLR4/Akt/FoxO1 Axis in IL-1β-Stimulated SW1353 Cells. Drug Des. Devel Ther. 2020;14:2079–2090. doi: 10.2147/DDDT.S244059.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S244059</ArticleId><ArticleId IdType="pmc">PMC7274521</ArticleId><ArticleId IdType="pubmed">32581510</ArticleId></ArticleIdList></Reference><Reference><Citation>Csaki C., Mobasheri A., Shakibaei M. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: Inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res. Ther. 2009;11:R165. doi: 10.1186/ar2850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2850</ArticleId><ArticleId IdType="pmc">PMC3003513</ArticleId><ArticleId IdType="pubmed">19889203</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Sun X., Huang K., Shen S., Lin X., Xie Z., Wang J., Fan S., Ma J., Zhao X. Sanguinarine protects against osteoarthritis by suppressing the expression of catabolic proteases. Oncotarget. 2017;8:62900–62913. doi: 10.18632/oncotarget.17036.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.17036</ArticleId><ArticleId IdType="pmc">PMC5609890</ArticleId><ArticleId IdType="pubmed">28968958</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao S., Zhou K., Li D., Xie X., Jun F., Wang J. Schisantherin A suppresses interleukin-1β-induced inflammation in human chondrocytes via inhibition of NF-κB and MAPKs activation. Eur. J. Pharmacol. 2016;780:65–70. doi: 10.1016/j.ejphar.2016.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2016.03.032</ArticleId><ArticleId IdType="pubmed">26997368</ArticleId></ArticleIdList></Reference><Reference><Citation>Phitak T., Pothacharoen P., Settakorn J., Poompimol W., Caterson B., Kongtawelert P. Chondroprotective and anti-inflammatory effects of sesamin. Phytochemistry. 2012;80:77–88. doi: 10.1016/j.phytochem.2012.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phytochem.2012.05.016</ArticleId><ArticleId IdType="pubmed">22704650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.A., Yeo Y., Jung H.A., Jung Y.O., Park S.J., Kim S.J. Phase 2 enzyme inducer sulphoraphane blocks prostaglandin and nitric oxide synthesis in human articular chondrocytes and inhibits cartilage matrix degradation. Rheumatology. 2012;51:1006–1016. doi: 10.1093/rheumatology/ker525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ker525</ArticleId><ArticleId IdType="pubmed">22332123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.A., Yeo Y., Kim W.U., Kim S. Phase 2 enzyme inducer sulphoraphane blocks matrix metalloproteinase production in articular chondrocytes. Rheumatology. 2009;48:932–938. doi: 10.1093/rheumatology/kep132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kep132</ArticleId><ArticleId IdType="pubmed">19491303</ArticleId></ArticleIdList></Reference><Reference><Citation>Facchini A., Stanic I., Cetrullo S., Borzì R.M., Filardo G., Flamigni F. Sulforaphane protects human chondrocytes against cell death induced by various stimuli. J. Cell Physiol. 2011;226:1771–1779. doi: 10.1002/jcp.22506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22506</ArticleId><ArticleId IdType="pubmed">21506109</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson R.K., Jupp O., de Ferrars R., Kay C.D., Culley K.L., Norton R., Driscoll C., Vincent T.L., Donell S.T., Bao Y., et al. Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo. Arthritis Rheum. 2013;65:3130–3140. doi: 10.1002/art.38133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38133</ArticleId><ArticleId IdType="pmc">PMC4240673</ArticleId><ArticleId IdType="pubmed">23983046</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson R., Gardner S., Jupp O., Bullough A., Butters S., Watts L., Donell S., Traka M., Saha S., Mithen R., et al. Isothiocyanates are detected in human synovial fluid following broccoli consumption and can affect the tissues of the knee joint. Sci. Rep. 2017;7:3398. doi: 10.1038/s41598-017-03629-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-03629-5</ArticleId><ArticleId IdType="pmc">PMC5469854</ArticleId><ArticleId IdType="pubmed">28611391</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko J.Y., Choi Y.J., Jeong G.J., Im G.I. Sulforaphane-PLGA microspheres for the intra-articular treatment of osteoarthritis. Biomaterials. 2013;34:5359–5368. doi: 10.1016/j.biomaterials.2013.03.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2013.03.066</ArticleId><ArticleId IdType="pubmed">23601658</ArticleId></ArticleIdList></Reference><Reference><Citation>Piao T., Ma Z., Li X., Liu J. Taraxasterol inhibits IL-1β-induced inflammatory response in human osteoarthritic chondrocytes. Eur. J. Pharmacol. 2015;756:38–42. doi: 10.1016/j.ejphar.2015.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2015.03.012</ArticleId><ArticleId IdType="pubmed">25797286</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C., Jeong J.W., Lee D.S., Yim M.J., Lee J.M., Han M.H., Kim S., Kim H.S., Kim G.Y., Park E.K., et al. Extract Attenuates Interleukin-1β-Induced Oxidative Stress and Inflammatory Response in Chondrocytes by Suppressing the Activation of NF-κB, p38 MAPK, and PI3K/Akt. Int. J. Mol. Sci. 2018;19:2308. doi: 10.3390/ijms19082308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19082308</ArticleId><ArticleId IdType="pmc">PMC6121501</ArticleId><ArticleId IdType="pubmed">30087236</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Qiao J., Zhao X., Chen T., Guan D. Thymoquinone Inhibits IL-1β-Induced Inflammation in Human Osteoarthritis Chondrocytes by Suppressing NF-κB and MAPKs Signaling Pathway. Inflammation. 2015;38:2235–2241. doi: 10.1007/s10753-015-0206-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-015-0206-1</ArticleId><ArticleId IdType="pubmed">26156811</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N.M., Haseeb A., Ansari M.Y., Haqqi T.M. A wogonin-rich-fraction of Scutellaria baicalensis root extract exerts chondroprotective effects by suppressing IL-1β-induced activation of AP-1 in human OA chondrocytes. Sci. Rep. 2017;7:43789. doi: 10.1038/srep43789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43789</ArticleId><ArticleId IdType="pmc">PMC5335554</ArticleId><ArticleId IdType="pubmed">28256567</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N.M., Haseeb A., Ansari M.Y., Devarapalli P., Haynie S., Haqqi T.M. Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human Osteoarthritis chondrocytes. Free Radic. Biol. Med. 2017;106:288–301. doi: 10.1016/j.freeradbiomed.2017.02.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.02.041</ArticleId><ArticleId IdType="pmc">PMC5490997</ArticleId><ArticleId IdType="pubmed">28237856</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N.M., Ahmad I., Ansari M.Y., Haqqi T.M. Wogonin, a natural flavonoid, intercalates with genomic DNA and exhibits protective effects in IL-1β stimulated osteoarthritis chondrocytes. Chem. Biol. Interact. 2017;274:13–23. doi: 10.1016/j.cbi.2017.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2017.06.025</ArticleId><ArticleId IdType="pmc">PMC5548605</ArticleId><ArticleId IdType="pubmed">28688942</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma P., Yue L., Yang H., Fan Y., Bai J., Li S., Yuan J., Zhang Z., Yao C., Lin M., et al. Chondroprotective and anti-inflammatory effects of amurensin H by regulating TLR4/Syk/NF-κB signals. J. Cell Mol. Med. 2020;24:1958–1968. doi: 10.1111/jcmm.14893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14893</ArticleId><ArticleId IdType="pmc">PMC6991675</ArticleId><ArticleId IdType="pubmed">31876072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Liu Q., Wang K. Artesunate attenuates ACLT-induced osteoarthritis by suppressing osteoclastogenesis and aberrant angiogenesis. Biomed. Pharmacother. 2017;96:410–416. doi: 10.1016/j.biopha.2017.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.10.018</ArticleId><ArticleId IdType="pubmed">29031199</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Z., Guo X.H., Tang C., Yue S.T., Shi L., Qiang B. Effects of Artesunate on the Expressions of Insulin-Like Growth Factor-1, Osteopontin and C-Telopeptides of Type II Collagen in a Rat Model of Osteoarthritis. Pharmacology. 2018;101:1–8. doi: 10.1159/000479160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000479160</ArticleId><ArticleId IdType="pubmed">28898893</ArticleId></ArticleIdList></Reference><Reference><Citation>Boumediene K., Felisaz N., Bogdanowicz P., Galera P., Guillou G.B., Pujol J.P. Avocado/soya unsaponifiables enhance the expression of transforming growth factor beta1 and beta2 in cultured articular chondrocytes. Arthritis Rheum. 1999;42:148–156. doi: 10.1002/1529-0131(199901)42:1&lt;148::AID-ANR18&gt;3.0.CO;2-U.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199901)42:1&lt;148::AID-ANR18&gt;3.0.CO;2-U</ArticleId><ArticleId IdType="pubmed">9920025</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Afify A.S.A., El-Akabawy G., El-Sherif N.M., El-Safty F.E.A., El-Habiby M.M. Avocado soybean unsaponifiables ameliorates cartilage and subchondral bone degeneration in mono-iodoacetate-induced knee osteoarthritis in rats. Tissue Cell. 2018;52:108–115. doi: 10.1016/j.tice.2018.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tice.2018.05.001</ArticleId><ArticleId IdType="pubmed">29857819</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinecke L.F., Grzanna M.W., Au A.Y., Mochal C.A., Rashmir-Raven A., Frondoza C.G. Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. Osteoarthr. Cartil. 2010;18:220–227. doi: 10.1016/j.joca.2009.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2009.08.015</ArticleId><ArticleId IdType="pubmed">19748608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ownby S.L., Fortuno L.V., Au A.Y., Grzanna M.W., Rashmir-Raven A.M., Frondoza C.G. Expression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination. J. Inflamm. 2014;11:8. doi: 10.1186/1476-9255-11-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-9255-11-8</ArticleId><ArticleId IdType="pmc">PMC3983882</ArticleId><ArticleId IdType="pubmed">24678847</ArticleId></ArticleIdList></Reference><Reference><Citation>Frondoza C.G., Fortuno L.V., Grzanna M.W., Ownby S.L., Au A.Y., Rashmir-Raven A.M. α-Lipoic Acid Potentiates the Anti-Inflammatory Activity of Avocado/Soybean Unsaponifiables in Chondrocyte Cultures. Cartilage. 2018;9:304–312. doi: 10.1177/1947603516686146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1947603516686146</ArticleId><ArticleId IdType="pmc">PMC6042030</ArticleId><ArticleId IdType="pubmed">29156944</ArticleId></ArticleIdList></Reference><Reference><Citation>Grzanna M.W., Secor E.J., Fortuno L.V., Au A.Y., Frondoza C.G. Anti-Inflammatory Effect of Carprofen Is Enhanced by Avocado/Soybean Unsaponifiables, Glucosamine and Chondroitin Sulfate Combination in Chondrocyte Microcarrier Spinner Culture. Cartilage. 2020;11:108–116. doi: 10.1177/1947603518783495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1947603518783495</ArticleId><ArticleId IdType="pmc">PMC6921959</ArticleId><ArticleId IdType="pubmed">29938530</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Zhu P., Liu R., Meng Q., Li S. Baicalin promotes extracellular matrix synthesis in chondrocytes via the activation of hypoxia-inducible factor-1α. Exp. Ther. Med. 2020;20:226. doi: 10.3892/etm.2020.9356.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2020.9356</ArticleId><ArticleId IdType="pmc">PMC7646699</ArticleId><ArticleId IdType="pubmed">33193840</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y., Chen D., Lu Q., Liu L., Li X., Li Z. Baicalin prevents the apoptosis of endplate chondrocytes by inhibiting the oxidative stress induced by H2O2. Mol. Med. Rep. 2017;16:2985–2991. doi: 10.3892/mmr.2017.6904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6904</ArticleId><ArticleId IdType="pubmed">28677799</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon P.D., Jeong H.S., Chun C.S., Kim H.M. Baekjeolyusin-tang and its active component berberine block the release of collagen and proteoglycan from IL-1β-stimulated rabbit cartilage and down-regulate matrix metalloproteinases in rabbit chondrocytes. Phytother. Res. 2011;25:844–850. doi: 10.1002/ptr.3353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.3353</ArticleId><ArticleId IdType="pubmed">21089182</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu P.F., Chen W.P., Tang J.L., Bao J.P., Wu L.D. Protective effects of berberine in an experimental rat osteoarthritis model. Phytother. Res. 2011;25:878–885. doi: 10.1002/ptr.3359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.3359</ArticleId><ArticleId IdType="pubmed">21108488</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Zhang T., Xia C., Shi L., Wang S., Zheng X., Hu T., Zhang B. Berberine ameliorates cartilage degeneration in interleukin-1β-stimulated rat chondrocytes and in a rat model of osteoarthritis via Akt signalling. J. Cell Mol. Med. 2014;18:283–292. doi: 10.1111/jcmm.12186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12186</ArticleId><ArticleId IdType="pmc">PMC3930415</ArticleId><ArticleId IdType="pubmed">24286347</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu S.Q., Yu L., He B., Wu S.H., Zhao Q., Xia S.Q., Mei H.J. Berberine prevents nitric oxide-induced rat chondrocyte apoptosis and cartilage degeneration in a rat osteoarthritis model via AMPK and p38 MAPK signaling. Apoptosis. 2015;20:1187–1199. doi: 10.1007/s10495-015-1152-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-015-1152-y</ArticleId><ArticleId IdType="pubmed">26184498</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Tao H., Li Y., Deng M., He B., Xia S., Zhang C., Liu S. Berberine promotes proliferation of sodium nitroprusside-stimulated rat chondrocytes and osteoarthritic rat cartilage via Wnt/β-catenin pathway. Eur. J. Pharmacol. 2016;789:109–118. doi: 10.1016/j.ejphar.2016.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2016.07.027</ArticleId><ArticleId IdType="pubmed">27445236</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., He P., Hou Y., Chen S., Xiao Z., Zhan J., Luo D., Gu M., Lin D. Berberine inhibits the interleukin-1 beta-induced inflammatory response via MAPK downregulation in rat articular chondrocytes. Drug Dev. Res. 2019;80:637–645. doi: 10.1002/ddr.21541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ddr.21541</ArticleId><ArticleId IdType="pubmed">31032997</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng K., Chen H., Xu C. Chondro-protective effects of celastrol on osteoarthritis through autophagy activation and NF-κB signaling pathway inhibition. Inflamm. Res. 2020;69:385–400. doi: 10.1007/s00011-020-01327-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01327-z</ArticleId><ArticleId IdType="pubmed">32112120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Ha C., Lin T., Wang D., Wang Y., Gong M. Celastrol attenuates pain and cartilage damage via SDF-1/CXCR4 signalling pathway in osteoarthritis rats. J. Pharm. Pharmacol. 2018;70:81–88. doi: 10.1111/jphp.12835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jphp.12835</ArticleId><ArticleId IdType="pubmed">28994112</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D.D., Zhang B.L., Yang J.B., Zhou K. Celastrol ameliorates endoplasmic stress-mediated apoptosis of osteoarthritis via regulating ATF-6/CHOP signalling pathway. J. Pharm. Pharmacol. 2020;72:826–835. doi: 10.1111/jphp.13250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jphp.13250</ArticleId><ArticleId IdType="pubmed">32201950</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin T., Wu D., Liu X.M., Xu J.T., Ma B.J., Ji Y., Jin Y.Y., Wu S.Y., Wu T., Ma K. Intra-articular delivery of celastrol by hollow mesoporous silica nanoparticles for pH-sensitive anti-inflammatory therapy against knee osteoarthritis. J. Nanobiotechnology. 2020;18:94. doi: 10.1186/s12951-020-00651-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-020-00651-0</ArticleId><ArticleId IdType="pmc">PMC7346635</ArticleId><ArticleId IdType="pubmed">32641147</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S., Siddiqi M.H., Yoon S.J., Ahn S., Noh H.Y., Kumar N.S., Kim Y.J., Yang D.C. Therapeutic potential of compound K as an IKK inhibitor with implications for osteoarthritis prevention: An in silico and in vitro study. In Vitro Cell Dev. Biol. Anim. 2016;52:895–905. doi: 10.1007/s11626-016-0062-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11626-016-0062-9</ArticleId><ArticleId IdType="pubmed">27368432</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei M., Guo C., Hua L., Xue S., Yu D., Zhang C., Wang D. Crocin Attenuates Joint Pain and Muscle Dysfunction in Osteoarthritis Rat. Inflammation. 2017;40:2086–2093. doi: 10.1007/s10753-017-0648-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-017-0648-8</ArticleId><ArticleId IdType="pubmed">28785878</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q., Zhong H., Qi Y., Cheng Y., Li W., Yan S., Wang X. Anti-arthritic effects of crocin in interleukin-1β-treated articular chondrocytes and cartilage in a rabbit osteoarthritic model. Inflamm. Res. 2013;62:17–25. doi: 10.1007/s00011-012-0546-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-012-0546-3</ArticleId><ArticleId IdType="pubmed">22903188</ArticleId></ArticleIdList></Reference><Reference><Citation>Clutterbuck A.L., Mobasheri A., Shakibaei M., Allaway D., Harris P. Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation. Ann. N. Y. Acad. Sci. 2009;1171:428–435. doi: 10.1111/j.1749-6632.2009.04687.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2009.04687.x</ArticleId><ArticleId IdType="pubmed">19723086</ArticleId></ArticleIdList></Reference><Reference><Citation>Clutterbuck A.L., Allaway D., Harris P., Mobasheri A. Curcumin reduces prostaglandin E2, matrix metalloproteinase-3 and proteoglycan release in the secretome of interleukin 1β-treated articular cartilage. F1000Res. 2013;2:147. doi: 10.12688/f1000research.2-147.v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.2-147.v2</ArticleId><ArticleId IdType="pmc">PMC3901452</ArticleId><ArticleId IdType="pubmed">24555068</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Ma J., Gu J.H., Wang F.Y., Shang X.S., Tao H.R., Wang X. Regulation of type II collagen, matrix metalloproteinase-13 and cell proliferation by interleukin-1β is mediated by curcumin via inhibition of NF-κB signaling in rat chondrocytes. Mol. Med. Rep. 2017;16:1837–1845. doi: 10.3892/mmr.2017.6771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6771</ArticleId><ArticleId IdType="pmc">PMC5562050</ArticleId><ArticleId IdType="pubmed">28627596</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Feng K., Li J., Yu D., Fan Q., Tang T., Yao X., Wang X. Curcumin Inhibits Apoptosis of Chondrocytes through Activation ERK1/2 Signaling Pathways Induced Autophagy. Nutrients. 2017;9:414. doi: 10.3390/nu9040414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9040414</ArticleId><ArticleId IdType="pmc">PMC5409753</ArticleId><ArticleId IdType="pubmed">28430129</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan D., He B., Guo J., Li S., Wang J. Involvement of TLR4 in the protective effect of intra-articular administration of curcumin on rat experimental osteoarthritis. Acta Cir. Bras. 2019;34:e201900604. doi: 10.1590/s0102-865020190060000004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0102-865020190060000004</ArticleId><ArticleId IdType="pmc">PMC6705335</ArticleId><ArticleId IdType="pubmed">31432995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.L., Lee H.J., Lee D.R., Choi B.K., Yang S.H. Herbal Composition LI73014F2 Alleviates Articular Cartilage Damage and Inflammatory Response in Monosodium Iodoacetate-Induced Osteoarthritis in Rats. Molecules. 2020;25:5467. doi: 10.3390/molecules25225467.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25225467</ArticleId><ArticleId IdType="pmc">PMC7700416</ArticleId><ArticleId IdType="pubmed">33238379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q.H., Ye C.Y., Chen E.M., Zhang W., Wang X.H. Emodin ameliorates cartilage degradation in osteoarthritis by inhibiting NF-κB and Wnt/β-catenin signaling in-vitro and in-vivo. Int. Immunopharmacol. 2018;61:222–230. doi: 10.1016/j.intimp.2018.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2018.05.026</ArticleId><ArticleId IdType="pubmed">29890416</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Lang Y., Li L., Liang Z., Deng Y., Fang R., Meng Q. Effect of emodin on chondrocyte viability in an. Exp. Ther. Med. 2018;16:5384–5389. doi: 10.3892/etm.2018.6877.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6877</ArticleId><ArticleId IdType="pmc">PMC6257384</ArticleId><ArticleId IdType="pubmed">30542499</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H., Song X., Li Y., Ma T., Bai H., Zhao M., Wang X., Liu L., Gao L. Emodin protects knee joint cartilage in rats through anti-matrix degradation pathway: An in vitro and in vivo study. Life Sci. 2021;269:119001. doi: 10.1016/j.lfs.2020.119001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.119001</ArticleId><ArticleId IdType="pubmed">33421527</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron J.P., Gandy J.C., Brown J.L., Sordillo L.M. Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1β-stimulated equine synoviocytes. Prostaglandins Other Lipid Mediat. 2019;142:1–8. doi: 10.1016/j.prostaglandins.2019.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prostaglandins.2019.02.007</ArticleId><ArticleId IdType="pubmed">30836143</ArticleId></ArticleIdList></Reference><Reference><Citation>Wann A.K., Mistry J., Blain E.J., Michael-Titus A.T., Knight M.M. Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation. Arthritis Res. Ther. 2010;12:R207. doi: 10.1186/ar3183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3183</ArticleId><ArticleId IdType="pmc">PMC3046514</ArticleId><ArticleId IdType="pubmed">21059244</ArticleId></ArticleIdList></Reference><Reference><Citation>Zainal Z., Longman A.J., Hurst S., Duggan K., Caterson B., Hughes C.E., Harwood J.L. Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthr. Cartil. 2009;17:896–905. doi: 10.1016/j.joca.2008.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2008.12.009</ArticleId><ArticleId IdType="pubmed">19217322</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Shou K., Gong C., Yang H., Yang Y., Bao T. Anti-Inflammatory Effect of Geniposide on Osteoarthritis by Suppressing the Activation of p38 MAPK Signaling Pathway. Biomed. Res. Int. 2018;2018:8384576. doi: 10.1155/2018/8384576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/8384576</ArticleId><ArticleId IdType="pmc">PMC5846349</ArticleId><ArticleId IdType="pubmed">29682561</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan T., Shi X., Chen H., Chen R., Wu D., Lin Z., Zhang J., Pan J. Geniposide Suppresses Interleukin-1β-Induced Inflammation and Apoptosis in Rat Chondrocytes via the PI3K/Akt/NF-κB Signaling Pathway. Inflammation. 2018;41:390–399. doi: 10.1007/s10753-017-0694-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-017-0694-2</ArticleId><ArticleId IdType="pubmed">29214554</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W.J., Bao T.Z., Chen K., Zhu C.M., Wan F., Tan Y.L., Yan F. Effects of geniposide on SNP-induced apoptosis of chondrocyte and cell cycle. Zhongguo Gu Shang. 2013;26:232–235.</Citation><ArticleIdList><ArticleId IdType="pubmed">23795444</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J., Ding W., Wu N., Jiang S., Li W. Protective Effect of Genistein on Condylar Cartilage through Downregulating NF- Biomed. Res. Int. 2019;2019:2629791. doi: 10.1155/2019/2629791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/2629791</ArticleId><ArticleId IdType="pmc">PMC7011344</ArticleId><ArticleId IdType="pubmed">32083119</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Z., Crane J., Xie H., Jin X., Zhen G., Li C., Xie L., Wang L., Bian Q., Qiu T., et al. Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone. Ann. Rheum. Dis. 2016;75:1714–1721. doi: 10.1136/annrheumdis-2015-207923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2015-207923</ArticleId><ArticleId IdType="pmc">PMC5013081</ArticleId><ArticleId IdType="pubmed">26470720</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu W., Xu B., Ma H., Li J., Ji B., Zhang Z., Amat A., Cao L. Halofuginone Attenuates Osteoarthritis by Rescuing Bone Remodeling in Subchondral Bone Through Oral Gavage. Front. Pharmacol. 2018;9:269. doi: 10.3389/fphar.2018.00269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00269</ArticleId><ArticleId IdType="pmc">PMC5881118</ArticleId><ArticleId IdType="pubmed">29636687</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu W., Xu B., Ma H., Ji B., Zhang Z., Li J., Amat A., Cao L. Halofuginone attenuates articular cartilage degeneration by inhibition of elevated TGF-β1 signaling in articular cartilage in a rodent osteoarthritis model. Mol. Med. Rep. 2017;16:7679–7684. doi: 10.3892/mmr.2017.7549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.7549</ArticleId><ArticleId IdType="pubmed">28944864</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrubasik J.E., Lindhorst E., Neumann E., Gerlach U., Faller-Marquardt M., Torda T., Müller-Ladner U., Chrubasik S. Potential molecular basis of the chondroprotective effect of Harpagophytum procumbens. Phytomedicine. 2006;13:598–600. doi: 10.1016/j.phymed.2006.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2006.01.014</ArticleId><ArticleId IdType="pubmed">16500096</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong D., Geng C., Jiang L., Cao J., Yoshimura H., Zhong L. Effects of hydroxytyrosol-20 on carrageenan-induced acute inflammation and hyperalgesia in rats. Phytother. Res. 2009;23:646–650. doi: 10.1002/ptr.2686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.2686</ArticleId><ArticleId IdType="pubmed">19067390</ArticleId></ArticleIdList></Reference><Reference><Citation>Takuma M., Haruka K., Mutsuto W., Toshiki M., Kenshiro M., Akane T., Hiroshi M., Yoshihiro N. Olive leaf extract prevents cartilage degeneration in osteoarthritis of STR/ort mice. Biosci. Biotechnol. Biochem. 2018;82:1101–1106. doi: 10.1080/09168451.2018.1451741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09168451.2018.1451741</ArticleId><ArticleId IdType="pubmed">29587623</ArticleId></ArticleIdList></Reference><Reference><Citation>Mével E., Merceron C., Vinatier C., Krisa S., Richard T., Masson M., Lesoeur J., Hivernaud V., Gauthier O., Abadie J., et al. Olive and grape seed extract prevents post-traumatic osteoarthritis damages and exhibits in vitro anti IL-1β activities before and after oral consumption. Sci. Rep. 2016;6:33527. doi: 10.1038/srep33527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33527</ArticleId><ArticleId IdType="pmc">PMC5027597</ArticleId><ArticleId IdType="pubmed">27640363</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun K., Luo J., Jing X., Xiang W., Guo J., Yao X., Liang S., Guo F., Xu T. Hyperoside ameliorates the progression of osteoarthritis: An in vitro and in vivo study. Phytomedicine. 2021;80:153387. doi: 10.1016/j.phymed.2020.153387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2020.153387</ArticleId><ArticleId IdType="pubmed">33130473</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W., Zhang H., Liu D., Jiao F. Icariin accelerates cartilage defect repair by promoting chondrogenic differentiation of BMSCs under conditions of oxygen-glucose deprivation. J. Cell Mol. Med. 2022;26:202–215. doi: 10.1111/jcmm.17073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17073</ArticleId><ArticleId IdType="pmc">PMC8742234</ArticleId><ArticleId IdType="pubmed">34859578</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang W., Zhang J., Wang R., Wang L., Wang S., Wu Y., Dong Y., Guo F., Xu T. Role of IFT88 in icariin-regulated maintenance of the chondrocyte phenotype. Mol. Med. Rep. 2018;17:4999–5006. doi: 10.3892/mmr.2018.8486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2018.8486</ArticleId><ArticleId IdType="pmc">PMC5865960</ArticleId><ArticleId IdType="pubmed">29393439</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Zhang Z.F., Qin F.W., Tang W., Liu D.H., Wu P.Y., Jiao F. Icariin inhibits chondrocyte apoptosis and angiogenesis by regulating the TDP-43 signaling pathway. Mol. Genet. Genomic Med. 2019;7:e00586. doi: 10.1002/mgg3.586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mgg3.586</ArticleId><ArticleId IdType="pmc">PMC6465670</ArticleId><ArticleId IdType="pubmed">30734541</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Mi B., Lv H., Liu J., Xiong Y., Hu L., Xue H., Panayi A.C., Liu G., Zhou W. Shared KEGG pathways of icariin-targeted genes and osteoarthritis. J. Cell Biochem. 2018;120:7741–7750. doi: 10.1002/jcb.28048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.28048</ArticleId><ArticleId IdType="pubmed">30506715</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Tang W., Zhang H., Huang H., Zhang Z., Tang D., Jiao F. Icariin protects rabbit BMSCs against OGD-induced apoptosis by inhibiting ERs-mediated autophagy via MAPK signaling pathway. Life Sci. 2020;253:117730. doi: 10.1016/j.lfs.2020.117730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117730</ArticleId><ArticleId IdType="pubmed">32348838</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W.P., Hu Z.N., Jin L.B., Wu L.D. Licochalcone A Inhibits MMPs and ADAMTSs via the NF-κB and Wnt/β-Catenin Signaling Pathways in Rat Chondrocytes. Cell Physiol. Biochem. 2017;43:937–944. doi: 10.1159/000481645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000481645</ArticleId><ArticleId IdType="pubmed">28957807</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z., Qi W., Zhan J., Lin Z., Lin J., Xue X., Pan X., Zhou Y. Activating Nrf2 signalling alleviates osteoarthritis development by inhibiting inflammasome activation. J. Cell Mol. Med. 2020;24:13046–13057. doi: 10.1111/jcmm.15905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15905</ArticleId><ArticleId IdType="pmc">PMC7701566</ArticleId><ArticleId IdType="pubmed">32965793</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S., Wang S., He J., Bian Y. Tetramethylpyrazine alleviates endoplasmic reticulum stress-activated apoptosis and related inflammation in chondrocytes. Mol. Med. Rep. 2022;25:1–8. doi: 10.3892/mmr.2021.12528.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2021.12528</ArticleId><ArticleId IdType="pmc">PMC8600404</ArticleId><ArticleId IdType="pubmed">34779501</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Shi Y., Zhang Z., Yang Z., Huang G. Intra-articular delivery of tetramethylpyrazine microspheres with enhanced articular cavity retention for treating osteoarthritis. Asian J. Pharm. Sci. 2018;13:229–238. doi: 10.1016/j.ajps.2017.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajps.2017.12.007</ArticleId><ArticleId IdType="pmc">PMC7032152</ArticleId><ArticleId IdType="pubmed">32104396</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z., Feng Y., Li C., Yang K., Sun T., Xu L., Chen Y., Yan C.H., Lu W.W., Chiu K.Y. Magnoflorine with hyaluronic acid gel promotes subchondral bone regeneration and attenuates cartilage degeneration in early osteoarthritis. Bone. 2018;116:266–278. doi: 10.1016/j.bone.2018.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2018.08.015</ArticleId><ArticleId IdType="pubmed">30149068</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z., Hong M., Xu L., Yang K., Li C., Sun T., Feng Y., Zeng H., Lu W.W., Chiu K.Y. Prevent action of magnoflorine with hyaluronic acid gel from cartilage degeneration in anterior cruciate ligament transection induced osteoarthritis. Biomed. Pharmacother. 2020;126:109733. doi: 10.1016/j.biopha.2019.109733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.109733</ArticleId><ArticleId IdType="pubmed">32113051</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacono A., Gómez R., Sperry J., Conde J., Bianco G., Meli R., Gómez-Reino J.J., Smith A.B., Gualillo O. Effect of oleocanthal and its derivatives on inflammatory response induced by lipopolysaccharide in a murine chondrocyte cell line. Arthritis Rheum. 2010;62:1675–1682. doi: 10.1002/art.27437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.27437</ArticleId><ArticleId IdType="pubmed">20201078</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotece M., Gómez R., Conde J., Lopez V., Gómez-Reino J.J., Lago F., Smith A.B., Gualillo O. Further evidence for the anti-inflammatory activity of oleocanthal: Inhibition of MIP-1α and IL-6 in J774 macrophages and in ATDC5 chondrocytes. Life Sci. 2012;91:1229–1235. doi: 10.1016/j.lfs.2012.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2012.09.012</ArticleId><ArticleId IdType="pubmed">23044226</ArticleId></ArticleIdList></Reference><Reference><Citation>Aini H., Ochi H., Iwata M., Okawa A., Koga D., Okazaki M., Sano A., Asou Y. Procyanidin B3 prevents articular cartilage degeneration and heterotopic cartilage formation in a mouse surgical osteoarthritis model. PLoS ONE. 2012;7:e37728. doi: 10.1371/journal.pone.0037728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037728</ArticleId><ArticleId IdType="pmc">PMC3358274</ArticleId><ArticleId IdType="pubmed">22629448</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda I., Koike M., Nakashima S., Mizutani Y., Ozawa Y., Watanabe K., Sawada Y., Sugiyama H., Sugimoto A., Nojiri H., et al. Apple procyanidins promote mitochondrial biogenesis and proteoglycan biosynthesis in chondrocytes. Sci. Rep. 2018;8:7229. doi: 10.1038/s41598-018-25348-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25348-1</ArticleId><ArticleId IdType="pmc">PMC5940809</ArticleId><ArticleId IdType="pubmed">29739985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T.W., Wen Y.J., Song X.P., Hu H.L., Li Y., Bai H., Zhao M.C., Gao L. Puerarin inhibits the development of osteoarthritis through antiinflammatory and antimatrix-degrading pathways in osteoarthritis-induced rat model. Phytother. Res. 2020;35:2579–2593. doi: 10.1002/ptr.6988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6988</ArticleId><ArticleId IdType="pubmed">33350519</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Huang C., Sun H., Hong H., Jin J., Bei C., Lu Z., Zhang X. Puerarin suppresses inflammation and ECM degradation through Nrf2/HO-1 axis in chondrocytes and alleviates pain symptom in osteoarthritic mice. Food Funct. 2021;12:2075–2089. doi: 10.1039/D0FO03076G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0FO03076G</ArticleId><ArticleId IdType="pubmed">33543180</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Shan H., Wang B., Wang N., Zhou Z., Pan C., Wang F. Puerarin Attenuates Osteoarthritis via Upregulating AMP-Activated Protein Kinase/Proliferator-Activated Receptor-γ Coactivator-1 Signaling Pathway in Osteoarthritis Rats. Pharmacology. 2018;102:117–125. doi: 10.1159/000490418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000490418</ArticleId><ArticleId IdType="pubmed">29961054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei B., Zhang Y., Tang L., Ji Y., Yan C., Zhang X. Protective effects of quercetin against inflammation and oxidative stress in a rabbit model of knee osteoarthritis. Drug Dev. Res. 2019;80:360–367. doi: 10.1002/ddr.21510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ddr.21510</ArticleId><ArticleId IdType="pubmed">30609097</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Gui Z., Zhou Y., Xia L., Lin K., Xu Y. Quercetin alleviates rat osteoarthritis by inhibiting inflammation and apoptosis of chondrocytes, modulating synovial macrophages polarization to M2 macrophages. Free Radic. Biol. Med. 2019;145:146–160. doi: 10.1016/j.freeradbiomed.2019.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.09.024</ArticleId><ArticleId IdType="pubmed">31550528</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Yin J., Zhao D., Wang C., Zhang Y., Wang Y., Li T. Therapeutic effect and mechanism of action of quercetin in a rat model of osteoarthritis. J. Int. Med. Res. 2020;48:300060519873461. doi: 10.1177/0300060519873461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060519873461</ArticleId><ArticleId IdType="pmc">PMC7607207</ArticleId><ArticleId IdType="pubmed">31842639</ArticleId></ArticleIdList></Reference><Reference><Citation>Permatasari D.A., Karliana D., Iskandarsyah I., Arsianti A., Bahtiar A. Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats. J. Adv. Pharm. Technol. Res. 2019;10:2–8. doi: 10.4103/japtr.JAPTR_331_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/japtr.JAPTR_331_18</ArticleId><ArticleId IdType="pmc">PMC6383352</ArticleId><ArticleId IdType="pubmed">30815381</ArticleId></ArticleIdList></Reference><Reference><Citation>Britti D., Crupi R., Impellizzeri D., Gugliandolo E., Fusco R., Schievano C., Morittu V.M., Evangelista M., Di Paola R., Cuzzocrea S. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models. BMC Vet. Res. 2017;13:229. doi: 10.1186/s12917-017-1151-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12917-017-1151-z</ArticleId><ArticleId IdType="pmc">PMC5541643</ArticleId><ArticleId IdType="pubmed">28768536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Gao J.S., Chen J.W., Li F., Tian J. Effect of resveratrol on cartilage protection and apoptosis inhibition in experimental osteoarthritis of rabbit. Rheumatol. Int. 2012;32:1541–1548. doi: 10.1007/s00296-010-1720-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-010-1720-y</ArticleId><ArticleId IdType="pubmed">21327438</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmali N., Esenkaya I., Harma A., Ertem K., Turkoz Y., Mizrak B. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm. Res. 2005;54:158–162. doi: 10.1007/s00011-004-1341-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-004-1341-6</ArticleId><ArticleId IdType="pubmed">15883738</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y., Jia J., Jin X., Tong W., Tian H. Resveratrol ameliorates inflammatory damage and protects against osteoarthritis in a rat model of osteoarthritis. Mol. Med. Rep. 2018;17:1493–1498. doi: 10.3892/mmr.2017.8036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.8036</ArticleId><ArticleId IdType="pmc">PMC5780088</ArticleId><ArticleId IdType="pubmed">29138829</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu H., Li K., Li X., Yu X., Wang W., Ding L., Liu L. Oral Resveratrol Prevents Osteoarthritis Progression in C57BL/6J Mice Fed a High-Fat Diet. Nutrients. 2016;8:233. doi: 10.3390/nu8040233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu8040233</ArticleId><ArticleId IdType="pmc">PMC4848701</ArticleId><ArticleId IdType="pubmed">27104565</ArticleId></ArticleIdList></Reference><Reference><Citation>Horcajada M.N., Sanchez C., Membrez Scalfo F., Drion P., Comblain F., Taralla S., Donneau A.F., Offord E.A., Henrotin Y. Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig. Osteoarthr. Cartil. 2015;23:94–102. doi: 10.1016/j.joca.2014.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2014.08.016</ArticleId><ArticleId IdType="pubmed">25219641</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y., Huang Y., Santoso M.B., Wu L.D. Sclareol exerts anti-osteoarthritic activities in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model. Int. J. Clin. Exp. Pathol. 2015;8:2365–2374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4440052</ArticleId><ArticleId IdType="pubmed">26045743</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu D., Shang X., Ni Z., Shi G. Shikonin inhibits inflammation and chondrocyte apoptosis by regulation of the PI3K/Akt signaling pathway in a rat model of osteoarthritis. Exp. Ther. Med. 2016;12:2735–2740. doi: 10.3892/etm.2016.3642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3642</ArticleId><ArticleId IdType="pmc">PMC5038895</ArticleId><ArticleId IdType="pubmed">27703516</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Yin Z., Zhou B., Xue F., Yang W., Chang R., Ma K., Qiu Y. Shikonin inhibits inflammatory responses in rabbit chondrocytes and shows chondroprotection in osteoarthritic rabbit knee. Int. Immunopharmacol. 2015;29:656–662. doi: 10.1016/j.intimp.2015.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2015.09.014</ArticleId><ArticleId IdType="pubmed">26395917</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Gai P., Xu R., Zheng Y., Lv S., Li Y., Liu S. Shikonin protects chondrocytes from interleukin-1beta-induced apoptosis by regulating PI3K/Akt signaling pathway. Int. J. Clin. Exp. Pathol. 2015;8:298–308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4348881</ArticleId><ArticleId IdType="pubmed">25755716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju X.D., Deng M., Ao Y.F., Yu C.L., Wang J.Q., Yu J.K., Cui G.Q., Hu Y.L. Protective effect of sinomenine on cartilage degradation and chondrocytes apoptosis. Yakugaku Zasshi. 2010;130:1053–1060. doi: 10.1248/yakushi.130.1053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/yakushi.130.1053</ArticleId><ArticleId IdType="pubmed">20686209</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Lin Z., Yan Z., Wang Z., Fu X., Yu K. Sinomenine contributes to the inhibition of the inflammatory response and the improvement of osteoarthritis in mouse-cartilage cells by acting on the Nrf2/HO-1 and NF-κB signaling pathways. Int. Immunopharmacol. 2019;75:105715. doi: 10.1016/j.intimp.2019.105715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2019.105715</ArticleId><ArticleId IdType="pubmed">31310911</ArticleId></ArticleIdList></Reference><Reference><Citation>Javaheri B., Poulet B., Aljazzar A., de Souza R., Piles M., Hopkinson M., Shervill E., Pollard A., Chan B., Chang Y.M., et al. Stable sulforaphane protects against gait anomalies and modifies bone microarchitecture in the spontaneous STR/Ort model of osteoarthritis. Bone. 2017;103:308–317. doi: 10.1016/j.bone.2017.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2017.07.028</ArticleId><ArticleId IdType="pmc">PMC5571892</ArticleId><ArticleId IdType="pubmed">28778596</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudirman S., Chen C.K., Long B.T., Chang H.W., Tsou D., Kong Z.L. Nut Triterpene-Rich Extract Ameliorates Symptoms of Inflammation on Post-Traumatic Osteoarthritis in Obese Rats. J. Pain. Res. 2020;13:261–271. doi: 10.2147/JPR.S228766.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S228766</ArticleId><ArticleId IdType="pmc">PMC6997037</ArticleId><ArticleId IdType="pubmed">32099450</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.S., Lee H.J., Lee D.Y., Jo H.S., Jeong J.H., Kim D.H., Nam D.C., Lee C.J., Hwang S.C. Chondroprotective Effects of Wogonin in Experimental Models of Osteoarthritis in vitro and in vivo. Biomol. Ther. 2015;23:442–448. doi: 10.4062/biomolther.2015.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.4062/biomolther.2015.045</ArticleId><ArticleId IdType="pmc">PMC4556204</ArticleId><ArticleId IdType="pubmed">26336584</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J.F., Starr E.G., Goodman M.A., Hanson R.B., Palmer T.A., Woolstenhulme J.B., Weyand J.A., Marchant A.D., Bueckers S.L., Nelson T.K., et al. Topical Application of Wogonin Provides a Novel Treatment of Knee Osteoarthritis. Front. Physiol. 2020;11:80. doi: 10.3389/fphys.2020.00080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00080</ArticleId><ArticleId IdType="pmc">PMC7040489</ArticleId><ArticleId IdType="pubmed">32132930</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson O.S., Sant K.E., Dolinoy D.C. Nutrition and epigenetics: An interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J. Nutr. Biochem. 2012;23:853–859. doi: 10.1016/j.jnutbio.2012.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2012.03.003</ArticleId><ArticleId IdType="pmc">PMC3405985</ArticleId><ArticleId IdType="pubmed">22749138</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.W., Friso S. Epigenetics: A New Bridge between Nutrition and Health. Adv. Nutr. 2010;1:8–16. doi: 10.3945/an.110.1004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.110.1004</ArticleId><ArticleId IdType="pmc">PMC3042783</ArticleId><ArticleId IdType="pubmed">22043447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari A., Bhawal S., Kapila S., Yadav H., Kapila R. Health-promoting role of dietary bioactive compounds through epigenetic modulations: A novel prophylactic and therapeutic approach. Crit. Rev. Food Sci. Nutr. 2022;62:619–639. doi: 10.1080/10408398.2020.1825286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2020.1825286</ArticleId><ArticleId IdType="pubmed">33081489</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahid F., Zand H., Nosrat-Mirshekarlou E., Najafi R., Hekmatdoost A. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: A review. Gene. 2015;562:8–15. doi: 10.1016/j.gene.2015.02.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.02.045</ArticleId><ArticleId IdType="pubmed">25701602</ArticleId></ArticleIdList></Reference><Reference><Citation>Langley-Evans S.C. Developmental programming of health and disease. Proc. Nutr. Soc. 2006;65:97–105. doi: 10.1079/PNS2005478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1079/PNS2005478</ArticleId><ArticleId IdType="pmc">PMC1885472</ArticleId><ArticleId IdType="pubmed">16441949</ArticleId></ArticleIdList></Reference><Reference><Citation>Chmurzynska A. Fetal programming: Link between early nutrition, DNA methylation, and complex diseases. Nutr. Rev. 2010;68:87–98. doi: 10.1111/j.1753-4887.2009.00265.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1753-4887.2009.00265.x</ArticleId><ArticleId IdType="pubmed">20137054</ArticleId></ArticleIdList></Reference><Reference><Citation>Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 2007;8:253–262. doi: 10.1038/nrg2045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2045</ArticleId><ArticleId IdType="pmc">PMC5940010</ArticleId><ArticleId IdType="pubmed">17363974</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucharski R., Maleszka J., Foret S., Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science. 2008;319:1827–1830. doi: 10.1126/science.1153069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1153069</ArticleId><ArticleId IdType="pubmed">18339900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G.L., Kodell R.L., Moore S.R., Cooney C.A. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J. 1998;12:949–957. doi: 10.1096/fasebj.12.11.949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.12.11.949</ArticleId><ArticleId IdType="pubmed">9707167</ArticleId></ArticleIdList></Reference><Reference><Citation>Aagaard-Tillery K.M., Grove K., Bishop J., Ke X., Fu Q., McKnight R., Lane R.H. Developmental origins of disease and determinants of chromatin structure: Maternal diet modifies the primate fetal epigenome. J. Mol. Endocrinol. 2008;41:91–102. doi: 10.1677/JME-08-0025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/JME-08-0025</ArticleId><ArticleId IdType="pmc">PMC2959100</ArticleId><ArticleId IdType="pubmed">18515302</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolinoy D.C., Weidman J.R., Waterland R.A., Jirtle R.L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect. 2006;114:567–572. doi: 10.1289/ehp.8700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.8700</ArticleId><ArticleId IdType="pmc">PMC1440782</ArticleId><ArticleId IdType="pubmed">16581547</ArticleId></ArticleIdList></Reference><Reference><Citation>Tain Y.L., Lee W.C., Wu K.L.H., Leu S., Chan J.Y.H. Resveratrol Prevents the Development of Hypertension Programmed by Maternal Plus Post-Weaning High-Fructose Consumption through Modulation of Oxidative Stress, Nutrient-Sensing Signals, and Gut Microbiota. Mol. Nutr. Food Res. 2018;62:e1800066. doi: 10.1002/mnfr.201800066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201800066</ArticleId><ArticleId IdType="pubmed">29710384</ArticleId></ArticleIdList></Reference><Reference><Citation>Remely M., Lovrecic L., de la Garza A.L., Migliore L., Peterlin B., Milagro F.I., Martinez A.J., Haslberger A.G. Therapeutic perspectives of epigenetically active nutrients. Br. J. Pharmacol. 2015;172:2756–2768. doi: 10.1111/bph.12854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12854</ArticleId><ArticleId IdType="pmc">PMC4439873</ArticleId><ArticleId IdType="pubmed">25046997</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery M., Srinivasan A. Epigenetic Gene Regulation by Dietary Compounds in Cancer Prevention. Adv. Nutr. 2019;10:1012–1028. doi: 10.1093/advances/nmz046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmz046</ArticleId><ArticleId IdType="pmc">PMC6855955</ArticleId><ArticleId IdType="pubmed">31100104</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W.J., Shim J.Y., Zhu B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 2005;68:1018–1030. doi: 10.1124/mol.104.008367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.104.008367</ArticleId><ArticleId IdType="pubmed">16037419</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005;6:597–610. doi: 10.1038/nrg1655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg1655</ArticleId><ArticleId IdType="pubmed">16136652</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M.M., Bird A. DNA methylation landscapes: Provocative insights from epigenomics. Nat. Rev. Genet. 2008;9:465–476. doi: 10.1038/nrg2341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2341</ArticleId><ArticleId IdType="pubmed">18463664</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M., Chen D., Yang C.S. Dietary polyphenols may affect DNA methylation. J. Nutr. 2007;137:223S–228S. doi: 10.1093/jn/137.1.223S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/137.1.223S</ArticleId><ArticleId IdType="pubmed">17182830</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron E.E., Bachman K.E., Myöhänen S., Herman J.G., Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 1999;21:103–107. doi: 10.1038/5047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/5047</ArticleId><ArticleId IdType="pubmed">9916800</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar S., Kumar D., Srivastava R.K. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition. Pharmacol. Ther. 2013;138:1–17. doi: 10.1016/j.pharmthera.2012.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2012.11.002</ArticleId><ArticleId IdType="pmc">PMC4153856</ArticleId><ArticleId IdType="pubmed">23159372</ArticleId></ArticleIdList></Reference><Reference><Citation>Link A., Balaguer F., Goel A. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochem. Pharmacol. 2010;80:1771–1792. doi: 10.1016/j.bcp.2010.06.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2010.06.036</ArticleId><ArticleId IdType="pmc">PMC2974019</ArticleId><ArticleId IdType="pubmed">20599773</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Liu J., Sun Y., Wen J., Zhou Q., Ding X., Zhang X. Correlation analysis of differentially expressed long non-coding RNA HOTAIR with PTEN/PI3K/AKT pathway and inflammation in patients with osteoarthritis and the effect of baicalin intervention. J. Orthop. Surg. Res. 2023;18:34. doi: 10.1186/s13018-023-03505-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-023-03505-1</ArticleId><ArticleId IdType="pmc">PMC9835332</ArticleId><ArticleId IdType="pubmed">36635778</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Cheng J., Liu J. Baicalin Protects Human OA Chondrocytes Against IL-1β-Induced Apoptosis and ECM Degradation by Activating Autophagy via MiR-766-3p/AIFM1 Axis. Drug Des. Devel Ther. 2020;14:2645–2655. doi: 10.2147/DDDT.S255823.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S255823</ArticleId><ArticleId IdType="pmc">PMC7353997</ArticleId><ArticleId IdType="pubmed">32753846</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Zhang Q., Gao Z., Yu C., Zhang L. Baicalin alleviates IL-1β-induced inflammatory injury via down-regulating miR-126 in chondrocytes. Biomed. Pharmacother. 2018;99:184–190. doi: 10.1016/j.biopha.2018.01.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.01.041</ArticleId><ArticleId IdType="pubmed">29331857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Q., Qi D., Xu X., Xu Y., Goodman S.B., Kang L., Song Q., Fan Z., Maloney W.J., Wang Y. Cryptotanshinone Protects Cartilage against Developing Osteoarthritis through the miR-106a-5p/GLIS3 Axis. Mol. Ther. Nucleic Acids. 2018;11:170–179. doi: 10.1016/j.omtn.2018.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2018.02.001</ArticleId><ArticleId IdType="pmc">PMC5992348</ArticleId><ArticleId IdType="pubmed">29858052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Cao G., Ba X., Jiang H. Epigallocatechin-3-O-Gallate promotes extracellular matrix and inhibits inflammation in IL-1B stimulated chondrocytes by the PTEN/miRNA-29b pathway. Pharm. Biol. 2022;60:589–599. doi: 10.1080/13880209.2022.2039722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13880209.2022.2039722</ArticleId><ArticleId IdType="pmc">PMC8920401</ArticleId><ArticleId IdType="pubmed">35260041</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasheed Z., Rasheed N., Al-Shaya O. Epigallocatechin-3-O-gallate modulates global microRNA expression in interleukin-1β-stimulated human osteoarthritis chondrocytes: Potential role of EGCG on negative co-regulation of microRNA-140-3p and ADAMTS5. Eur. J. Nutr. 2018;57:917–928. doi: 10.1007/s00394-016-1375-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-016-1375-x</ArticleId><ArticleId IdType="pubmed">28110479</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasheed Z., Rasheed N., Al-Shobaili H.A. Epigallocatechin-3-O-gallate up-regulates microRNA-199a-3p expression by down-regulating the expression of cyclooxygenase-2 in stimulated human osteoarthritis chondrocytes. J. Cell Mol. Med. 2016;20:2241–2248. doi: 10.1111/jcmm.12897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12897</ArticleId><ArticleId IdType="pmc">PMC5134388</ArticleId><ArticleId IdType="pubmed">27515563</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W., Feng Z., You S., Zhang H., Tao Z., Wang Q., Chen H., Wu Y. Fisetin inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through activating SIRT1 and attenuates the progression of osteoarthritis in mice. Int. Immunopharmacol. 2017;45:135–147. doi: 10.1016/j.intimp.2017.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2017.02.009</ArticleId><ArticleId IdType="pubmed">28213268</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetrullo S., D’Adamo S., Guidotti S., Borzì R.M., Flamigni F. Hydroxytyrosol prevents chondrocyte death under oxidative stress by inducing autophagy through sirtuin 1-dependent and -independent mechanisms. Biochim. Biophys. Acta. 2016;1860:1181–1191. doi: 10.1016/j.bbagen.2016.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2016.03.002</ArticleId><ArticleId IdType="pubmed">26947008</ArticleId></ArticleIdList></Reference><Reference><Citation>Facchini A., Cetrullo S., D’Adamo S., Guidotti S., Minguzzi M., Borzì R.M., Flamigni F. Hydroxytyrosol prevents increase of osteoarthritis markers in human chondrocytes treated with hydrogen peroxide or growth-related oncogene α. PLoS ONE. 2014;9:e109724. doi: 10.1371/journal.pone.0109724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0109724</ArticleId><ArticleId IdType="pmc">PMC4184903</ArticleId><ArticleId IdType="pubmed">25279550</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Adamo S., Cetrullo S., Guidotti S., Borzì R.M., Flamigni F. Hydroxytyrosol modulates the levels of microRNA-9 and its target sirtuin-1 thereby counteracting oxidative stress-induced chondrocyte death. Osteoarthr. Cartil. 2017;25:600–610. doi: 10.1016/j.joca.2016.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2016.11.014</ArticleId><ArticleId IdType="pubmed">27914878</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Adamo S., Cetrullo S., Borzì R.M., Flamigni F. Effect of oxidative stress and 3-hydroxytyrosol on DNA methylation levels of miR-9 promoters. J. Cell Mol. Med. 2019;23:7885–7889. doi: 10.1111/jcmm.14657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14657</ArticleId><ArticleId IdType="pmc">PMC6815808</ArticleId><ArticleId IdType="pubmed">31496000</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao J., Yan W., Xu K., Chen M., Chen Z., Ran J., Xiong Y., Wu L. Oleanolic Acid Decreases IL-1. Oxid. Med. Cell Longev. 2020;2020:7517219. doi: 10.1155/2020/7517219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/7517219</ArticleId><ArticleId IdType="pmc">PMC7542488</ArticleId><ArticleId IdType="pubmed">33062145</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Nie J., Jiang P. Oleanolic acid mitigates interleukin-1β-induced chondrocyte dysfunction by regulating miR-148-3p-modulated FGF2 expression. J. Gene Med. 2020;22:e3169. doi: 10.1002/jgm.3169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgm.3169</ArticleId><ArticleId IdType="pubmed">32028542</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong S., Xu G., Li X., Guo S., Bai J., Zhao J., Chen L. Exosomes Derived from Quercetin-Treated Bone Marrow Derived Mesenchymal Stem Cells Inhibit the Progression of Osteoarthritis Through Delivering miR-124-3p to Chondrocytes. DNA Cell Biol. 2024;43:85–94. doi: 10.1089/dna.2023.0341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2023.0341</ArticleId><ArticleId IdType="pubmed">38241502</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C., Xing H., Wang C., Xu X., Hao Y., Qiu B. Resveratrol Improves the Progression of Osteoarthritis by Regulating the SIRT1-FoxO1 Pathway-Mediated Cholesterol Metabolism. Mediators Inflamm. 2023;2023:2936236. doi: 10.1155/2023/2936236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/2936236</ArticleId><ArticleId IdType="pmc">PMC9833897</ArticleId><ArticleId IdType="pubmed">36643587</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi H., Zhang W., Cui S.Y., Fan J.B., Zhu X.H., Liu W. Identification and validation of key long non-coding RNAs in resveratrol protect against IL-1β-treated chondrocytes via integrated bioinformatic analysis. J. Orthop. Surg. Res. 2021;16:421. doi: 10.1186/s13018-021-02574-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-021-02574-4</ArticleId><ArticleId IdType="pmc">PMC8252221</ArticleId><ArticleId IdType="pubmed">34215299</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Yang H., Hu B., Zhang M. Sirt1 regulates apoptosis and extracellular matrix degradation in resveratrol-treated osteoarthritis chondrocytes via the Wnt/β-catenin signaling pathways. Exp. Ther. Med. 2017;14:5057–5062. doi: 10.3892/etm.2017.5165.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2017.5165</ArticleId><ArticleId IdType="pmc">PMC5704318</ArticleId><ArticleId IdType="pubmed">29201214</ArticleId></ArticleIdList></Reference><Reference><Citation>Abed É., Delalandre A., Lajeunesse D. Beneficial effect of resveratrol on phenotypic features and activity of osteoarthritic osteoblasts. Arthritis Res. Ther. 2017;19:151. doi: 10.1186/s13075-017-1365-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-017-1365-2</ArticleId><ArticleId IdType="pmc">PMC5493084</ArticleId><ArticleId IdType="pubmed">28666466</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue S., Su X., Teng J., Wang J., Guo M. Cryptotanshinone interferes with chondrocyte apoptosis in osteoarthritis by inhibiting the expression of miR-574-5p. Mol. Med. Rep. 2021;23:424. doi: 10.3892/mmr.2021.12063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2021.12063</ArticleId><ArticleId IdType="pmc">PMC8047883</ArticleId><ArticleId IdType="pubmed">33878859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye H., Long Y., Yang J.M., Wu Y.L., Dong L.Y., Zhong Y.B., Luo Y., Wang M.Y. Curcumin regulates autophagy through SIRT3-SOD2-ROS signaling pathway to improve quadriceps femoris muscle atrophy in KOA rat model. Sci. Rep. 2024;14:8176. doi: 10.1038/s41598-024-58375-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-58375-2</ArticleId><ArticleId IdType="pmc">PMC11001965</ArticleId><ArticleId IdType="pubmed">38589505</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng K., Ge Y., Chen Z., Li X., Liu Z., Li H., Tang T., Yang F., Wang X. Curcumin Inhibits the PERK-eIF2. Oxid. Med. Cell Longev. 2019;2019:8574386. doi: 10.1155/2019/8574386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/8574386</ArticleId><ArticleId IdType="pmc">PMC6541984</ArticleId><ArticleId IdType="pubmed">31223428</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu B., Xu X., Yi P., Hao Y. Curcumin reinforces MSC-derived exosomes in attenuating osteoarthritis via modulating the miR-124/NF-kB and miR-143/ROCK1/TLR9 signalling pathways. J. Cell Mol. Med. 2020;24:10855–10865. doi: 10.1111/jcmm.15714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15714</ArticleId><ArticleId IdType="pmc">PMC7521270</ArticleId><ArticleId IdType="pubmed">32776418</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Li X., Zhou J., Lei Z., Yang X. Fisetin suppresses chondrocyte senescence and attenuates osteoarthritis progression by targeting sirtuin 6. Chem. Biol. Interact. 2024;390:110890. doi: 10.1016/j.cbi.2024.110890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2024.110890</ArticleId><ArticleId IdType="pubmed">38278314</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhi L.Q., Yao S.X., Liu H.L., Li M., Duan N., Ma J.B. Hydroxytyrosol inhibits the inflammatory response of osteoarthritis chondrocytes via SIRT6-mediated autophagy. Mol. Med. Rep. 2018;17:4035–4042. doi: 10.3892/mmr.2017.8353.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.8353</ArticleId><ArticleId IdType="pubmed">29286133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan H., Zhu T., Wang T., Guo Y., Liu Y., Zheng J. Quercetin Modulates Ferroptosis via the SIRT1/Nrf-2/HO-1 Pathway and Attenuates Cartilage Destruction in an Osteoarthritis Rat Model. Int. J. Mol. Sci. 2024;25:7461. doi: 10.3390/ijms25137461.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25137461</ArticleId><ArticleId IdType="pmc">PMC11242395</ArticleId><ArticleId IdType="pubmed">39000568</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng K., Chen Z., Pengcheng L., Zhang S., Wang X. Quercetin attenuates oxidative stress-induced apoptosis via SIRT1/AMPK-mediated inhibition of ER stress in rat chondrocytes and prevents the progression of osteoarthritis in a rat model. J. Cell Physiol. 2019;234:18192–18205. doi: 10.1002/jcp.28452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28452</ArticleId><ArticleId IdType="pubmed">30854676</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu L., Luo Y., Chen X. Quercetin attenuates mitochondrial dysfunction and biogenesis via upregulated AMPK/SIRT1 signaling pathway in OA rats. Biomed. Pharmacother. 2018;103:1585–1591. doi: 10.1016/j.biopha.2018.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.05.003</ArticleId><ArticleId IdType="pubmed">29864946</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C., Xing H., Wang C., Xu X., Hao Y., Qiu B. Resveratrol protection against IL-1β-induced chondrocyte damage via the SIRT1/FOXO1 signaling pathway. J. Orthop. Surg. Res. 2022;17:406. doi: 10.1186/s13018-022-03306-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-022-03306-y</ArticleId><ArticleId IdType="pmc">PMC9446849</ArticleId><ArticleId IdType="pubmed">36064420</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Zhang H., You W., Tang X., Li X., Gong Z. Therapeutic effect of Resveratrol in the treatment of osteoarthritis via the MALAT1/miR-9/NF-κB signaling pathway. Exp. Ther. Med. 2020;19:2343–2352. doi: 10.3892/etm.2020.8471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2020.8471</ArticleId><ArticleId IdType="pmc">PMC7027295</ArticleId><ArticleId IdType="pubmed">32104302</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei M., Wang J.G., Xiao D.M., Fan M., Wang D.P., Xiong J.Y., Chen Y., Ding Y., Liu S.L. Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-κB activity. Eur. J. Pharmacol. 2012;674:73–79. doi: 10.1016/j.ejphar.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2011.10.015</ArticleId><ArticleId IdType="pubmed">22044919</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan M., Zhang D., Yang M. Saikosaponin D alleviates inflammatory response of osteoarthritis and mediates autophagy via elevating microRNA-199-3p to target transcription Factor-4. J. Orthop. Surg. Res. 2024;19:151. doi: 10.1186/s13018-024-04607-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-024-04607-0</ArticleId><ArticleId IdType="pmc">PMC10882832</ArticleId><ArticleId IdType="pubmed">38389105</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H.C., Li P.N., Chen C.J., Xu X., Zhang H., Liu G., Zheng L.J., Li P. Sinomenine Attenuates Cartilage Degeneration by Regulating miR-223-3p/NLRP3 Inflammasome Signaling. Inflammation. 2019;42:1265–1275. doi: 10.1007/s10753-019-00986-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-019-00986-3</ArticleId><ArticleId IdType="pubmed">30847744</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Zhang Z., Liang W., Zeng J., Shao X., Xu L., Jia L., He X., Li H., Zheng C., et al. Tougu Xiaotong capsules may inhibit p38 MAPK pathway-mediated inflammation: In vivo and in vitro verification. J. Ethnopharmacol. 2020;249:112390. doi: 10.1016/j.jep.2019.112390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2019.112390</ArticleId><ArticleId IdType="pubmed">31760158</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>